PQRS Number NQF Number 1

Measure Title & Description

Meets Performance

59 Diabetes Mellitus: Hemoglobin A1c Poor Control3046F 3046F-8P (Note: Measures poor control. A lower perf 64 Diabetes Mellitus: Low Density Lipoprotein (LDL-C) 3048F Control

61 Diabetes Mellitus: High Blood Pressure Control G8919 & G8921

*5 *5

81 Individual Measures Reporting: Heart Failure: Angiotensin-Converting 4010F Enzyme (ACE) Inhibito 81 Measures Group Reporting: Heart Failure: Angiotensin-Converting 4010F & 3021F Enzyme (ACE) Inhibitor or

6 *7

*8 *8

67 Coronary Artery Disease (CAD): Antiplatelet Therapy 4086F 70 Coronary Artery Disease (CAD): Beta-Blocker Therapy4008F Prior Myocardial Infarction (MI) or Le -----------4008F 83 Individual Measures Reporting: Heart Failure: Beta-Blocker G8450 Therapy for Left Ventricular Syst

83 Measures Group Reporting: Heart Failure: Beta-Blocker G8450 & Therapy G8923 for Left Ventricular Systolic

9 12 14 18 19 20 21 22 23 24 28 30 31 32 *33

105 Major Depressive Disorder (MDD): Antidepressant G8126 Medication During Acute Phase for Patie 86 87 88 89

Primary Open Angle Glaucoma (POAG): Optic Nerve 2027F Evaluation Age-Related Macular Degeneration (AMD): Dilated 2019F Macular Examination Diabetic Retinopathy: Documentation of Presence 2021F or Absence of Macular Edema and Level o Diabetic Retinopathy: Communication with the Physician 5010F & G8397 Managing Ongoing Diabetes Care

270 Perioperative Care: Timing of Prophylactic Parenteral G8629 Antibiotic Ordering Physician G8630 268 Perioperative Care: Selection of Prophylactic Antibiotic 4041F First OR Second Generation Cepha 271 Perioperative Care: Discontinuation of Prophylactic 4049F Parenteral & 4046FAntibiotics (Non-Cardiac Proc 239 45 92 269

Perioperative Care: Venous Thromboembolism (VTE) 4044F Prophylaxis (When Indicated in ALL Pa Osteoporosis: Communication with the Physician 5015F Managing On-going Care Post-Fracture of Aspirin at Arrival for Acute Myocardial Infarction4084F (AMI) Perioperative Care: Timely Administration of Prophylactic 4048F Parenteral Antibiotics

420 Stroke and Stroke Rehabilitation: Deep Vein Thrombosis 4070F (DVT) Prophylaxis for Ischemic Stro 325 Stroke and Stroke Rehabilitation: Discharged on G8696 Antithrombotic Therapy

241 Stroke and Stroke Rehabilitation: Anticoagulant Therapy 4075F Prescribed for Atrial Fibrillation (AF

35 36 39 40

243 Stroke and Stroke Rehabilitation: Screening for Dysphagia 6010F & 6015F 244 Stroke and Stroke Rehabilitation: Rehabilitation Services G8699 Ordered 46 Screening or Therapy for Osteoporosis for Women G8399 Aged 65 Years and Older

41 43 44 45 46 47 48 49 50 51 52

45 Osteoporosis: Management Following Fracture of 3096F Hip, Spine or Distal Radius for Men and W 3095F G8633 49 Osteoporosis: Pharmacologic Therapy for Men and 4005F Women Aged 50 Years and Older 516 Coronary Artery Bypass Graft (CABG): Use of Internal 4110F Mammary Artery (IMA) in Patients wit 235 Coronary Artery Bypass Graft (CABG): Preoperative 4115F Beta-Blocker in Patients with Isolated CA 637 Perioperative Care: Discontinuation of Prophylactic 4043F Parenteral & G8702 Antibiotics (Cardiac Procedur 97 Medication Reconciliation 326 Advance Care Plan 98 99 100 91 102

1111F 1123F 1124F Urinary Incontinence: Assessment of Presence or 1090F Absence of Urinary Incontinence in Wome Urinary Incontinence: Characterization of Urinary 1091F Incontinence in Women Aged 65 Years an Urinary Incontinence: Plan of Care for Urinary Incontinence 0509F in Women Aged 65 Years and O Chronic Obstructive Pulmonary Disease (COPD): 3023F Spirometry Evaluation Chronic Obstructive Pulmonary Disease (COPD): 4025F Bronchodilator & G8924 Therapy

53 54 55

47 Asthma: Pharmacologic Therapy for Persistent Asthma 4140F & Ambulatory 1038F Care Setting 4144F & 1038F 90 Emergency Medicine: 12-Lead Electrocardiogram 3120F (ECG) Performed for Non-Traumatic Chest 93 Emergency Medicine: 12-Lead Electrocardiogram G8704 (ECG) Performed for Syncope

56 59 64 65 66 67 68 69 70 71

232 Emergency Medicine: Community-Acquired Pneumonia 2010F (CAP): Vital Signs 96 Emergency Medicine: Community-Acquired Pneumonia 4045F (CAP): Empiric Antibiotic 1 Asthma: Assessment of Asthma Control Ambulatory 2015FCare & 2016F Setting 69 Appropriate Treatment for Children with Upper Respiratory G8708 Infection (URI) 2 Appropriate Testing for Children with Pharyngitis 3210F & G8711

377 Hematology: Myelodysplastic Syndrome (MDS) and 3155F Acute Leukemias: Baseline Cytogenetic 378 Hematology: Myelodysplastic Syndrome (MDS): 3160F Documentation & 4090F of Iron Stores in Patients Re

380 Hematology: Multiple Myeloma: Treatment with 4100F Bisphosphonates 379 Hematology: Chronic Lymphocytic Leukemia (CLL): 3170F Baseline Flow Cytometry 387 Breast Cancer: Hormonal Therapy for Stage IC - IIIC 4179F Estrogen & 3374F Receptor/Progesterone & 3315F Recept 4179F & 3376F & 3315F 4179F & 3378F & 3315F

72

385 Colon Cancer: Chemotherapy for AJCC Stage III Colon G8927 Cancer & 3388F Patients

76 *81 *82 *83 84 85 86 87 89 90 91 93 99 100

464 323 321 393 395

Prevention of Catheter-Related Bloodstream Infections 6030F (CRBSI): Central Venous Catheter (CV Adult Kidney Disease: Hemodialysis Adequacy: Solute G8713 Adult Kidney Disease: Peritoneal Dialysis Adequacy: G8718 Solute Hepatitis C: Testing for Chronic Hepatitis C Confirmation 3265F of Hepatitis C Viremia Hepatitis C: Ribonucleic Acid (RNA) Testing Before 3218F Initiating & 4150F Treatment

396 Hepatitis C: HCV Genotype Testing Prior to Treatment 3266F & G8459 397 Hepatitis C: Antiviral Treatment Prescribed 4153F 398 Hepatitis C: HCV Ribonucleic Acid (RNA) Testing at 3220F Week & 12 G8461 of Treatment 401 Hepatitis C: Counseling Regarding Risk of Alcohol 4158F Consumption 394 Hepatitis C: Counseling Regarding Use of Contraception 4159F & Prior G8463 to Antiviral Therapy

653 Acute Otitis Externa (AOE): Topical Therapy 4130F 654 Acute Otitis Externa (AOE): Systemic Antimicrobial 4132F Therapy Avoidance of Inappropriate Us 391 Breast Cancer Resection Pathology Reporting: pT 3260F Category (Primary Tumor) and pN Categor

392 Colorectal Cancer Resection Pathology Reporting: G8721 pT Category (Primary Tumor) and pN Cate

102

389 Prostate Cancer: Avoidance of Overuse of Bone Scan 3270F for & Staging 3271F Low Risk Prostate Cancer P

104 106 107 108 109 110

390 Prostate Cancer: Adjuvant Hormonal Therapy for 4164F High Risk & G8465 Prostate Cancer Patients

103 Adult Major Depressive Disorder (MDD): Comprehensive 1040F & G8930 Diagnostic Evaluation: Diagnosis an 104 Adult Major Depressive Disorder (MDD): SuicideG8932 Risk Assessment 54 Rheumatoid Arthritis (RA): Disease Modifying Anti-Rheumatic 4187F Drug (DMARD) Therapy 50 Osteoarthritis (OA): Function and Pain Assessment 1006F 41 Preventive Care and Screening: Influenza Immunization G8482

111 112

43 Preventive Care and Screening: Pneumococcal Vaccination 4040F for Patients 65 Years and Older 31 Preventive Care and Screening: Breast Cancer Screening 3014F

113 116 117

*118

34 Preventive Care and Screening: Colorectal Cancer 3017F Screening 58 Antibiotic Treatment for Adults with Acute Bronchitis: 4124F Avoidance of Inappropriate Use 55 Diabetes Mellitus: Dilated Eye Exam 2022F 2024F 2026F 3072F 66 Coronary Artery Disease (CAD): Angiotensin-Converting G8935 Enzyme (ACE) Inhibitor or Angiotens -----------G8473

119

62 Diabetes: Medical Attention for Nephropathy

121 AQA 122 AQA 123 AQA

3060F 3061F 3062F 3066F G8506 Adult Kidney Disease: LaboratoryTesting (Lipid Profile) G8725

Adult Kidney Disease: Blood Pressure Management G8476 G8477 & 0513F Adult Kidney Disease: Patients On Erythropoiesis-Stimulating G0908 & 4171F Agent (ESA) - Hemoglobin Leve (NOTE: A lower performance rate is desirab

126 127 128

417 Diabetes Mellitus: Diabetic Foot and Ankle Care,G8404 Peripheral Neuropathy Neurological Evalu 416 Diabetes Mellitus: Diabetic Foot and Ankle Care,G8410 Ulcer Prevention Evaluation of Footwear 421 Preventive Care and Screening: Body Mass IndexG8420 (BMI) Screening and Follow-Up G8417 G8418 419 Documentation of Current Medications in the Medical G8427 Record 420 Pain Assessment and Follow-Up G8730 G8731

130 131

134

418 Preventive Care and Screening: Screening for Clinical G8431 Depression and Follow-Up Plan G8510 650 561 566 563

*137 *138 140 141 142 *143 *144

Melanoma: Continuity of Care Recall System 7010F Melanoma: Coordination of Care 5050F Age-Related Macular Degeneration (AMD): Counseling 4177F on Antioxidant Supplement Primary Open-Angle Glaucoma (POAG): Reduction 3284F of Intraocular Pressure (IOP) by 15% OR D 0517F & 3285F 51 Osteoarthritis (OA): Assessment for Use of Anti-Inflammatory 1007F or Analgesic Over-the-Counte 384 Oncology: Medical and Radiation Pain Intensity 1125F Quantified 1126F 383 Oncology: Medical and Radiation Plan of Care for 0521F Pain

145 146

510 Radiology: Exposure Time Reported for Procedures 6045F Using Fluoroscopy 508 Radiology: Inappropriate Use of Probably Benign 3343F Assessment Category in Mammography (NOTE: A lower performance rate is desirab

147 148 149 150 151 154 AQA

511 Nuclear Medicine: Correlation with Existing Imaging 3570F Studies for All Patients Undergoing Bon 322 Back Pain: Initial Visit 1130F 319 Back Pain: Physical Exam 315 Back Pain: Advice for Normal Activities 313 Back Pain: Advice Against Bed Rest Falls: Risk Assessment 2040F 4245F 4248F 3288F & 1100F

155 AQA 156 157 *159 *160 *160

382 455 404 405 405

Falls: Plan of Care 0518F Oncology: Radiation Dose Limits to Normal Tissues 0520F Thoracic Surgery: Recording of Clinical Stage Prior 3323F to Lung Cancer or Esophageal Cancer Rese HIV/AIDS: CD4+ Cell Count or CD4+ Percentage 3500F Individual Measures Reporting: HIV/AIDS: Pneumocystis 4280F Jiroveci Pneumonia (PCP) Prophylax Measures Group Reporting: HIV/AIDS: Pneumocystis 4280F Jiroveci & 3494F Pneumonia (PCP) Prophylaxis

*161 *161 *162 *162 163 *164 *165 *166 *167 *168 *169

406 Individual Measures Reporting: HIV/AIDS: Adolescent 4276Fand Adult Patients with HIV/AIDS Who 406 Measures Group Reporting: HIV/AIDS: Adolescent 4276F and Adult & 3492F Patients with HIV/AIDS Who Ar 4276F & 3490F 407 Individual Measures Reporting: HIV/AIDS: HIV RNA 3502F Control After Six Months of Potent Antire 3503F & 0575F 407 Measures Group Reporting: HIV/AIDS: HIV RNA Control 3502F & After 4270F Six Months of Potent Antiretro 3503F & 0575F & 4270F 56 Diabetes Mellitus: Foot Exam 2028F 129 Coronary Artery Bypass Graft (CABG): ProlongedG8569 Intubation (NOTE: A lower performance rate is desirab 130 Coronary Artery Bypass Graft (CABG): Deep Sternal G8571 Wound Infection Rate (NOTE: A lower performance rate is desirab 131 Coronary Artery Bypass Graft (CABG): Stroke G8573 (NOTE: A lower performance rate is desirab 114 Coronary Artery Bypass Graft (CABG): Postoperative G8575 Renal Failure (NOTE: A lower performance rate is desirab 115 Coronary Artery Bypass Graft (CABG): Surgical Re-exploration G8577 (NOTE: A lower performance rate is desirab 237 Coronary Artery Bypass Graft (CABG): Antiplatelet G8579 Medications at Discharge

*170 *171 172 173 AQA 176 AQA 177 AQA

238 Coronary Artery Bypass Graft (CABG): Beta-Blockers G8582 Administered at Discharge 118 Coronary Artery Bypass Graft (CABG): Anti-Lipid G8585 Treatment at Discharge

259 Hemodialysis Vascular Access Decision-Making by G8530 Surgeon to Maximize Placement of Autog Preventive Care and Screening: Unhealthy Alcohol 3016F Use Screening Rheumatoid Arthritis (RA): Tuberculosis Screening 3455F & 4195F Rheumatoid Arthritis (RA): Periodic Assessment of 3470F Disease Activity 3471F 3472F Rheumatoid Arthritis (RA): Functional Status Assessment 1170F Rheumatoid Arthritis (RA): Assessment and Classification 3475F of Disease Prognosis 3476F Rheumatoid Arthritis (RA): Glucocorticoid Management 4192F 4193F 4194F & 0540F Elder Maltreatment Screen and Follow-Up Plan G8733 G8734 Functional Outcome Assessment

178 AQA 179 AQA 180 AQA

181 AQA

182 AQA

183 184 185 *187 188 N/A *191 *192 193 194 195 *197

399 400 659 437

G8539 G8542 G8942 Hepatitis C: Hepatitis A Vaccination in Patients with 4148F HCV 3215F Hepatitis C: Hepatitis B Vaccination in Patients with 4149F HCV 3216F Endoscopy & Polyp Surveillance: Colonoscopy Interval 0529F for Patients with a History of Adenom Stroke and Stroke Rehabilitation: Thrombolytic Therapy G8600

Referral for Otologic Evaluation for Patients with G8556 Congenital or Traumatic Deformity of the E

565 Cataracts: 20/40 or Better Visual Acuity within 90 4175F Days Following Cataract Surgery 564 Cataracts: Complications within 30 Days Following G8627 Cataract Surgery Requiring Additional Sur (NOTE: A lower performance rate is desirab 454 Perioperative Temperature Management 4250F & 4255F 386 Oncology: Cancer Stage Documented 3300F 3301F 507 Radiology: Stenosis Measurement in Carotid Imaging 3100F Studies 74 Coronary Artery Disease (CAD): Lipid Control G8736 G8737 & 4013F & 0556F 79 Heart Failure: Left Ventricular Ejection Fraction (LVEF) G8738Assessment G8739 73 Ischemic Vascular Disease (IVD): Blood Pressure G8588 Management & G8590

*198 201

204 *205 *208 *209 *210 *211 *212 *213 *214 *215 *216 *217 *218 *219 *220 221 *222 *223 *224 225 226 *228 N/A 231 N/A 232 N/A

68 409 410 445

Ischemic Vascular Disease (IVD): Use of Aspirin or G8598 Another Antithrombotic HIV/AIDS: Sexually Transmitted Disease Screening 3511F for Chlamydia and Gonorrhea HIV/AIDS: Sexually Transmitted Disease Screening 3512F for Syphilis Functional Communication Measure - Spoken Language G8603 Comprehension

449 Functional Communication Measure - Attention G8606 448 Functional Communication Measure - Memory G8609 447 Functional Communication Measure - Motor Speech G8612 446 Functional Communication Measure - Reading G8615 444 Functional Communication Measure - Spoken Language G8618 Expression 442 Functional Communication Measure - Writing G8621

443 Functional Communication Measure - Swallowing G8624

422 Functional Deficit: Change in Risk-Adjusted Functional G8647Status for Patients with Knee Impairm G8648 423 Functional Deficit: Change in Risk-Adjusted Functional G8651Status for Patients with Hip Impairme G8652 424 Functional Deficit: Change in Risk-Adjusted Functional G8655Status for Patients with Lower Leg, Fo G8656 425 Functional Deficit: Change in Risk-Adjusted Functional G8659Status for Patients with Lumbar Spine G8660 426 Functional Deficit: Change in Risk-Adjusted Functional G8663Status for Patients with Shoulder Imp G8664 427 Functional Deficit: Change in Risk-Adjusted Functional G8667Status for Patients with Elbow, Wrist G8668 428 Functional Deficit: Change in Risk-Adjusted Functional G8671Status for Patients with Neck, Cranium G8672 562 Melanoma: Overutilization of Imaging Studies in3320F Melanoma 509 Radiology: Reminder System for Mammograms 7025F 28 Preventive Care and Screening: Tobacco Use: Screening 4004F and Cessation Intervention 1036F Heart Failure (HF): Left Ventricular Function (LVF) G8682 Testing Asthma: Tobacco Use: Screening - Ambulatory Care 1031F Setting Asthma: Tobacco Use: Intervention - Ambulatory 4000F Care Setting & 1032F 4001F & 1032F

*233

457 Thoracic Surgery: Recording of Performance Status 3328F Prior to Lung or Esophageal Cancer Rese

*234 236

458 Thoracic Surgery: Pulmonary Function Tests Before 3038F Major Anatomic Lung Resection (Pneum 18 Hypertension (HTN): Controlling High Blood Pressure G8752 & G8754

241 242* 242* 243* 244* N/A N/A N/A

75 Ischemic Vascular Disease (IVD): Complete Lipid G8593 Panel and & G8595 Low Density Lipoprotein (LDL-C) C Individual Reporting via Registry: Coronary Artery 1011F Disease & 0557F (CAD): Symptom Management 1012F Measures Group Reporting: Coronary Artery Disease 1010F (CAD): & 1011F Symptom & 0557F Management 1010F & 1012F 643 Cardiac Rehabilitation Patient Referral from an Outpatient 4500F Setting Hypertension: Blood Pressure Management

245 246 247 248 249

AQA AQA AQA AQA N/A

G8790 & G8793 G8790 & G8794 G8791 & G8793 G8791 & G8794 G8790 & G8795 & 4145F G8791 & G8795 & 4145F G8792 & G8793 & 4145F G8792 & G8794 & 4145F G8792 & G8795 & 4145F Chronic Wound Care: Use of Wound Surface Culture 4261F Technique in Patients with Chronic Skin Chronic Wound Care: Use of Wet to Dry Dressings 4266F in Patients with Chronic Skin Ulcers (Over Substance Use Disorders: Counseling Regarding Psychosocial 4320F and Pharmacologic Treatment Substance Use Disorders: Screening for Depression 1220F Among Patients with Substance Abuse o Barrett's Esophagus 3125F Radical Prostatectomy Pathology Reporting 3267F

250 N/A 251 N/A 252 254 255 256* 257* 258* 259* 260* N/A N/A N/A N/A N/A 261 N/A

Immunohistochemical (IHC) Evaluation of Human 3394F Epidermal Growth Factor Receptor 2 Testi 503 Anticoagulation for Acute Pulmonary Embolus Patients G8799

651 Ultrasound Determination of Pregnancy Location G8806 for Pregnant Patients with Abdominal Pain

652 Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant G8809 Women at Risk of Fetal Blood Expos Surveillance after Endovascular Abdominal Aortic G8813 Aneurysm Repair (EVAR) Statin Therapy at Discharge after Lower Extremity G8816 Bypass (LEB)

Rate of Open Repair of Small or Moderate Non-Ruptured G8818 Abdominal Aortic Aneurysms (AAA Rate of Endovascular Aneurysm Repair (EVAR) of G8826 Small or Moderate Non-Ruptured Abdomin Rate of Carotid Endarterectomy (CEA) for Asymptomatic G8834 Patients, without Major Complicati Referral for Otologic Evaluation for Patients with G8856 Acute or Chronic Dizziness

262 N/A 263 N/A

Image Confirmation of Successful Excision of ImageLocalized G8872 Breast Lesion Preoperative Diagnosis of Breast Cancer G8875

264* 265*

N/A

Sentinel Lymph Node Biopsy for Invasive Breast Cancer G8878 645 Biopsy Follow-Up G8883

269* 270* 271* 272* 273*

266 N/A 267 N/A 268 N/A N/A N/A N/A N/A N/A

Epilepsy: Seizure Type(s) and Current Seizure Frequency(ies) 1200F Epilepsy: Documentation of Etiology of Epilepsy 1205F or Epilepsy Syndrome Epilepsy: Counseling for Women of Childbearing4340F Potential with Epilepsy Inflammatory Bowel Disease (IBD): Type, Anatomic G0920 Location and Activity All Documented Inflammatory Bowel Disease (IBD): Preventive Care: G8859 Corticosteroid & 4142F Sparing Therapy

Inflammatory Bowel Disease (IBD): Preventive Care: G8860 Corticosteroid & G8861 Related Iatrogenic Injury Inflammatory Bowel Disease (IBD): Preventive Care: 4035F Influenza Immunization 4037F Inflammatory Bowel Disease (IBD): Preventive Care: G8864 Pneumococcal Immunization

274* 275*

N/A N/A

276* 277* 278*

N/A N/A N/A

Inflammatory Bowel Disease (IBD): Testing for Latent 3510F Tuberculosis & G8868 (TB) Before Initiating Ant 6150F Inflammatory Bowel Disease (IBD): Assessment of 3517F Hepatitis B Virus (HBV) Status Before Initi G8869 G8870 Sleep Apnea: Assessment of Sleep Symptoms G8839 Sleep Apnea: Severity Assessment at Initial Diagnosis G8842 Sleep Apnea: Positive Airway Pressure Therapy Prescribed G8845 & G8846

279*

N/A

Sleep Apnea: Assessment of Adherence to Positive G8851 Airway & G8852 Pressure Therapy

280*

N/A

Dementia: Staging of Dementia

281* 282* 283* 284* 285* 286*

N/A N/A N/A N/A N/A N/A

1490F 1491F 1493F Dementia: Cognitive Assessment 1494F Dementia: Functional Status Assessment 1175F Dementia: Neuropsychiatric Symptom Assessment 1181F Dementia: Management of Neuropsychiatric Symptoms G8947 & 4525F G8947 & 4526F Dementia: Screening for Depressive Symptoms 3725F Dementia: Counseling Regarding Safety Concerns 6101F

287* 288* 289* 290* 291* 292* 293* 294* 295* 296* 297* 298* 299* 300* 301*

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

6102F Dementia: Counseling Regarding Risks of Driving6110F Dementia: Caregiver Education and Support 4322F Parkinsons Disease: Annual Parkinsons Disease 1400F Diagnosis Review Parkinsons Disease: Psychiatric Disorders or Disturbances 3700F Assessment Parkinsons Disease: Cognitive Impairment or Dysfunction 3720F Assessment Parkinsons Disease: Querying about Sleep Disturbances 4328F Parkinsons Disease: Rehabilitative Therapy Options 4400F Parkinsons Disease: Parkinsons Disease Medical 4325F and Surgical Treatment Options Reviewed Hypertension: Appropriate Use of Aspirin or Other G8895 Anththrombotic Therapy Hypertension: Complete Lipid Profile Hypertension: Urine Protein Test Hypertension: Annual Serum Creatinine Test G8767 G8770 G8771 G8774

Hypertension: Diabetes Mellitus Screening Test G8777 Hypertension: Blood Pressure Control G8886

Hypertension: Low Density Lipoprotein (LDL-C) Control G8890

302*

N/A

Hypertension: Dietary and Physical Activity Modifications G8780 Appropriately Prescribed

303* 304*

N/A N/A 317 N/A

Cataracts: Improvement in Patients Visual Function G0913 within 90 Days Following Cataract Surge Cataracts: Patient Satisfaction within 90 Days Following G0916 Cataract Surgery

Preventive Care and Screening: Screening for High G8783 Blood Pressure and Follow-Up Document G8950

320 321 322* 323* 324* 325* 326 N/A

658 Endoscopy/Polyp Surveillance: Appropriate Follow-Up 0528F Interval for Normal Colonoscopy in A 493 Participation by a Hospital, Physician or Other Clinician G8954 in a Systematic Clinical Database Reg 670 Cardiac Stress Imaging Not Meeting AppropriateG8961 Use Criteria: Preoperative Evaluation in Low (NOTE: A lower performance rate is desirab 671 Cardiac Stress Imaging Not Meeting AppropriateG8963 Use Criteria: Routine Testing After Percutan (NOTE: A lower performance rate is desirab 672 Cardiac Stress Imaging Not Meeting AppropriateG8965 Use Criteria: Testing in Asyptomatic, Low-R (NOTE: A lower performance rate is desirab Adult Major Depressive Disorder (MDD): Coordination G8959of Care of Patients with Comorbid Co 1525 Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation G8967 & G8972 Therapy

327 N/A 328

Pediatric Kidney Disease: Adequacy of Volume Management G8955 & G8956

1667 Pediatric Kidney Disease: ESRD Patients Receiving G8973 Dialysis: Hemoglobin Level < 10 g/dL (NOTE: A lower performance rate is desirab

Medical Performance Patient Performance System Performance Other Performance Performance Exclusion Exclusion Exclusion Exclusion Not Met N/A N/A N/A No Report 3044F 3045F poor control. A lower performance rate indicates better control.) N/A N/A N/A No Report 3049F 3050F 3048F-8P N/A N/A N/A No Report G8919 & G8922 G8920 & G8921 G8920 & G8922 2000F-8P 4010F-1P 4010F-2P 4010F-3P No Report 4010F-8P 4010F-1P &4010F-2P 3021F &4010F-3P 3021F &3022F 3021F 4010F-8P & 3021F 3021F-8P No Report 4086F-1P 4086F-2P 4086F-3P No Report 4086F-8P 4008F-1P 4008F-2P 4008F-3P No Report 4008F-8P ------------ ------------ ------------ ------------ -----------4008F-1P 4008F-2P 4008F-3P No Report 4008F-8P N/A N/A N/A G8451 G8452 No Report N/A N/A N/A G8541 G8452 G8395 G8923 G8396 No Report N/A N/A N/A G8128 G8127 No Report 2027F-1P N/A N/A No Report 2027F-8P 2019F-1P 2019F-2P N/A No Report 2019F-8P 2021F-1P 2021F-2P N/A No Report 2021F-8P 5010F-1P &5010F-2P G8397 &N/A G8397 G8398 5010F-8P & G8397 No Report N/A N/A N/A G8631 G8632 No Report 4041F-1P N/A N/A No Report 4041F-8P 4049F-1P &N/A 4046F N/A 4042F 4049F-8P & 4046F No Report 4044F-1P N/A N/A No Report 4044F-8P 5015F-1P 5015F-2P N/A No Report 5015F-8P 4084F-1P 4084F-2P N/A No Report 4084F-8P 4048F-1P N/A N/A 4047F-8P 4048F-8P No Report 4070F-1P 4070F-2P N/A No Report 4070F-8P N/A N/A N/A G8697 G8698 No Report 4075F-1P 4075F-2P N/A No Report 4075F-8P

6010F-1P &6010F-2P 6015F &N/A 6015F

6020F No Report N/A N/A N/A G8700 No Report N/A N/A N/A G8401 No Report 3096F-1P 3096F-2P 3096F-3P G8634 3095F-1P 3095F-2P 3095F-3P No Report

6010F-8P & 6015F G8701 G8400

3096F-8P 3095F-8P G8635 4005F-1P 4005F-2P 4005F-3P No Report 4005F-8P 4110F-1P N/A N/A No Report 4110F-8P 4115F-1P N/A N/A No Report 4115F-8P 4043F-1P &N/A G8702 N/A G8703 4043F-8P & G8702 No Report N/A N/A N/A No Report 1111F-8P N/A N/A N/A No Report 1123F-8P 1090F-1P N/A N/A No Report N/A N/A N/A No Report N/A N/A N/A No Report 3023F-1P 3023F-2P 3023F-3P No Report 4025F-1P &4025F-2P G8924 &4025F-3P G8924 &G8925 G8924 G8926 No Report N/A 4140F-2P &N/A 1038F 1039F No Report 3120F-1P 3120F-2P N/A No Report N/A N/A N/A G8705 G8706 No Report N/A N/A N/A No Report 4045F-1P 4045F-2P 4045F-3P No Report N/A N/A N/A No Report N/A N/A N/A 1090F-8P 1091F-8P 0509F-8P 3023F-8P 4025F-8P & G8924

4140F-8P & 1038F 3120F-8P G8707

G8709 No Report 3210F-1P &N/A G8711 N/A G8712 3210F-8P & G8711 No Report 3155F-1P 3155F-2P 3155F-3P No Report 3155F-8P N/A N/A 3160F-3P &4095F 4090F 3160F-8P & 4090F No Report 4100F-1P 4100F-2P N/A No Report 4100F-8P 3170F-1P 3170F-2P 3170F-3P No Report 3170F-8P 4179F-1P &4179F-2P 3374F & 3315F &4179F-3P 3374F & 3315F &3316F 3374F & 3315F 4179F-8P & 3374F & 3315F 4179F-1P &4179F-2P 3376F & 3315F &4179F-3P 3376F & 3315F &3370F 3376F & 3315F 4179F-8P & 3376F & 3315F 4179F-1P &4179F-2P 3378F & 3315F &4179F-3P 3378F & 3315F &3372F 3378F & 3315F 4179F-8P & 3378F & 3315F 3380F

2010F-8P 4045F-8P 2015F-8P 2016F-8P G8710

3316F-8P 3370F-8P No Report N/A N/A N/A G8928 & 3388F G8929 & 3388F 3382F 3384F 3386F 3390F 3382F-8P No Report 6030F-1P N/A N/A No Report 6030F-8P N/A N/A N/A No Report G8717 N/A N/A N/A No Report G8720 3265F-1P 3265F-2P N/A No Report 3265F-8P 3218F-1P &N/A 4150F N/A 4151F 3218F-8P & 4150F No Report N/A N/A N/A G8458 3266F-8P & G8459 No Report 4153F-1P 4153F-2P 4153F-3P No Report 4153F-8P 3220F-1P &3220F-2P G8461 &N/A G8461 G8460 3220F-8P & G8461 No Report N/A N/A N/A No Report 4158F-8P 4159F-1P &N/A G8463 N/A G8462 4159F-8P & G8463 No Report 4130F-1P 4130F-2P N/A No Report 4130F-8P 4131F-1P N/A N/A No Report 4131F 3260F-1P N/A N/A 3250F 3260F-8P No Report N/A N/A N/A G8722 G8724 G8723 No Report 3269F-1P &N/A 3271F 3269F-3P &3272F 3271F 3269F & 3271F 3273F 3274F No Report 4164F-1P &4164F-2P G8465 &N/A G8465 G8464 4164F-8P & G8465 No Report N/A N/A N/A No Report 1040F-8P & G8931 N/A N/A N/A 3092F G8933 No Report 4187F-1P N/A N/A No Report 4187F-8P N/A N/A N/A No Report 1006F-8P N/A N/A N/A G8483 G8484 G0919 No Report 4040F-1P N/A N/A No Report 4040F-8P 3014F-1P N/A N/A No Report 3014F-8P

3017F-1P N/A 4120F-1P N/A N/A N/A

N/A N/A N/A

No Report 3017F-8P No Report 4120F No Report 2022F-8P 2024F-8P 2026F-8P G8936 No Report -----------G8474 No Report No Report G8937 -----------G8475

N/A

N/A

N/A

N/A

N/A

N/A

3060F-8P 3061F-8P 3062F-8P

G8726 G8728 No Report N/A N/A N/A No Report G8478 0513F-8P & G8477 N/A N/A N/A G0909 & 4171F G0910 & 4171F erformance rate is desirable for this measure) 4172F No Report N/A N/A N/A G8406 G8405 No Report N/A N/A N/A G8416 G8415 No Report N/A N/A N/A G8422 G8421 G8938 G8419 No Report N/A N/A N/A G8430 G8428 No Report N/A N/A N/A G8442 G8732 G8939 G8509 No Report N/A N/A N/A G8433 G8432 G8940 G8511 No Report N/A N/A 7010F-3P No Report 7010F-8P N/A 5050F-2P 5050F-3P No Report 5050F-8P N/A N/A N/A No Report 4177F-8P N/A N/A N/A No Report 0517F-8P & 3285F 3284F-8P N/A N/A N/A No Report 1007F-8P N/A N/A N/A No Report 1125F-8P N/A N/A N/A No Report 0521F-8P

N/A

N/A

N/A

N/A N/A N/A No Report 6045F-8P N/A N/A N/A No Report 3340F erformance rate is desirable for this measure) 3341F 3342F 3344F 3345F 3350F N/A N/A 3570F-3P No Report 3570F-8P N/A N/A N/A 0526F 1130F-8P No Report N/A N/A N/A 0526F 2040F8P No Report N/A N/A N/A 0526F 4245F-8P No Report N/A N/A N/A 0526F 4248F-8P No Report 3288F-1P &N/A 1100F N/A 1101F 3288F-8P & 1100F 1101F-8P No Report 0518F-1P N/A N/A No Report 0518F-8P N/A N/A N/A No Report 0520F-8P N/A N/A N/A No Report 3323F-8P N/A N/A N/A No Report 3500F-8P 4280F-1P N/A N/A No Report 4280F-8P 4280F-1P &N/A 3494F N/A No Report 3494F-8P 3495F 4280F-8P & 3494F 3496F N/A N/A N/A No Report 4276F-8P N/A N/A N/A 3493F 4276F-8P & 3492F No Report 4276F-8P & 3490F N/A N/A N/A No Report 3502F-8P 0575F-8P & 3503F N/A N/A N/A 4271F 3502F-8P & 4270F No Report 0575F-8P & 3503F & 4270F 2028F-1P N/A N/A No Report 2028F-8P N/A N/A N/A No Report G8570 erformance rate is desirable for this measure) N/A N/A N/A No Report G8572 erformance rate is desirable for this measure) N.A N/A N/A No Report G8574 erformance rate is desirable for this measure) N/A N/A N/A No Report G8576 erformance rate is desirable for this measure) N/A N/A N/A No Report G8578 erformance rate is desirable for this measure) N/A N/A N/A G8580 G8581 No Report

N/A N/A N/A

N/A N/A N/A

N/A N/A N/A N/A N/A N/A

3016F-1P N/A 3455F-1P &N/A 4195F N/A N/A

G8583 No Report G8586 No Report G8531 No Report No Report 4196F No Report No Report

G8584 G8587 G8532 3016F-8P 3455F-8P & 4195F 3470F-8P

N/A N/A

N/A N/A

N/A N/A N/A

No Report 1170F-8P No Report 3475F-8P No Report 4194F-8P 0540F-8P & 4194F G8535 G8941 No Report G8540 No Report G8536 G8735 G8541 G8543

0540F-1P &N/A 4194F

N/A

N/A

N/A

N/A

N/A

N/A

4148F-1P 4148F-2P N/A 4149F-1P 4149F-2P N/A 0529F-1P N/A N/A N/A

No Report 4148F-8P No Report 4149F-8P 0529F-8P G8602 G8558 4175F-8P G8628 4250F-8P & 4255F 3301F-8P

0529F-3P No Report N/A G8601 No Report N/A N/A N/A G8557 No Report N/A N/A N/A No Report N/A N/A N/A No Report erformance rate is desirable for this measure) 4250F-1P &N/A 4255F N/A 4256F No Report N/A N/A N/A No Report

N/A N/A N/A No Report 3100F-8P G8737 & 0556F G8737 & 4013F-1P & 0556F G8737 & 4013F-2P & 0556F No Report & 4013F-3P G8737 & 4013F-8P G8737 & 0556F-8P G8943 N/A N/A N/A No Report G8740 N/A N/A N/A No Report G8588 & G8591

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

N/A 3511F-2P 3512F-2P N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

No Report No Report No Report No Report No Report No Report No Report No Report No Report No Report No Report

3319F-1P N/A N/A N/A 4004F-1P N/A N/A N/A N/A N/A N/A N/A

G8649 No Report N/A G8653 No Report N/A G8657 No Report N/A G8661 No Report N/A G8665 No Report N/A G8669 No Report N/A G8673 No Report 3319F-3P No Report N/A No Report N/A No Report N/A N/A N/A G8683 No Report No Report 1033F No Report

G8589 & G8590 G8589 & G8591 G8592 G8599 3511F-8P 3512F-8P G8604 G8605 G8607 G8608 G8610 G8611 G8613 G8614 G8616 G8617 G8619 G8620 G8622 G8623 G8625 G8626 G8650 G8654 G8658 G8662 G8666 G8670 G8674 3319F 7025F-8P 4004F-8P G8685

N/A

N/A

N/A

1031F-8P G8751 4000F-8P & 1032F 4001F-8P & 1032F No Report 3328F-8P

3038F-1P N/A N/A N/A

N/A N/A

N/A

N/A

N/A N/A

1011F & 0557F-1P N/A

No Report 3038F-8P No Report G8752 & G8755 G8753 & G8754 G8753 & G8755 G8756 No Report G8594 G8593 & G8597 No Report 1011F & 0557F-8P

1010F & 1011F N/A & 0557F-1P N/A

No Report 1010F & 1011F & 0557F-8P 1010F-8P 4500F-1P 4500F-2P 4500F-3P 4510F 4500F-8P No Report 4145F-1P 4145F-2P 4145F-3P No Report 4145F-8P G8796

4260F-1P 4265F-1P N/A 1220F-1P 3125F-1P

N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

3267F-1P N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

No Report No Report No Report No Report G8797 No Report G8798 No Report 3395F No Report G8800 No Report G8807 No Report G8810 No Report G8812 No Report G8815 No Report No Report No Report No Report G8857 No Report

4260F 4265F 4320F-8P 1220F-8P 3125F-8P 3267F-8P 3394F-8P G8801 G8808 G8811 G8814 G8817 G8825 G8833 G8838 G8858

N/A

G8873 No Report N/A N/A N/A G8876 G8946 No Report N/A N/A N/A G8880 No Report N/A N/A N/A G8884 No Report 1200F-1P 1200F-2P N/A No Report N/A N/A N/A No Report 4340F-1P N/A N/A No Report N/A G0921 N/A No Report G8859 & 4142F-1P G8859 & 4142F-2P N/A 3750F No Report N/A N/A N/A G8862 No Report 4035F-1P 4035F-2P 4035F-3P No Report 4037F-1P 4037F-2P 4037F-3P N/A N/A N/A G8865 G8866 No Report 3510F-1P &3510F-2P G8868 &N/A G8868 No Report 3517F-1P 3517F-2P N/A

N/A

N/A

G8874 G8877

G8882 G8885 1200F-8P 1205F-8P 4340F-8P G0922 G8859 & 4142F-8P G8860 & G8863 4035F-8P 4037F-8P G8867

3510F-8P & G8868

G8871 3517F-8P No Report G8840 G8841 No Report G8843 G8844 No Report G8848 G8850 & G8846 G8849 & G8846 No Report G8853 G8855 & G8852 G8854 & G8852 No Report No Report 1490F-8P

N/A N/A N/A

N/A N/A N/A

N/A N/A N/A

N/A

N/A

N/A

N/A

N/A

N/A

1494F-1P 1175F-1P N/A N/A

1494F-2P N/A N/A N/A

N/A N/A N/A N/A N/A N/A

N/A N/A 6101F-1P N/A

No Report No Report No Report G8948 No Report No Report No Report

1494F-8P 1175F-8P 1181F-8P G8947 & 4525F-8P G8947 & 4526F-8P 3725F-8P 6101F-8P

6102F-1P 6110F-1P 4322F-1P N/A N/A N/A 4328F-1P 4400F-1P 4325F-1P N/A N/A N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

N/A

N/A

N/A

N/A N/A N/A

N/A N/A N/A

N/A N/A N/A

0528F-1P N/A N/A N/A N/A N/A N/A N/A N/A erformance rate is desirable for this measure) N/A N/A N/A erformance rate is desirable for this measure) N/A N/A N/A erformance rate is desirable for this measure) N/A N/A N/A N/A N/A N/A

No Report No Report No Report No Report No Report No Report No Report No Report G8896 No Report G8768 No Report G8772 No Report G8775 No Report G8778 No Report G8887 No Report G8891 G8892 No Report G8781 G8949 No Report G0914 No Report G0917 No Report G8784 G8951 No Report No Report No Report No Report

6102F-8P 6110F-8P 4322F-8P 1400F-8P 3700F-8P 3720F-8P 4328F-8P 4400F-8P 4325F-8P G8897 G8769 G8773 G8776 G8779 G8888 G8889 G8893 G8894 G8782

G0915 G0918 G8785 G8952 0528F-8P N/A G8962

No Report G8964 No Report G8966 No Report G8960 G8968 & G8972 G8971 & G8972 G8969 & G8972 G8970 No Report

G8957 G8958 & G8956 No Report N/A N/A N/A G8974 G8976 erformance rate is desirable for this measure) G8975 No Report

N/A

N/A

N/A

PQRS_Number NQF_Number Measure Title_Description 1 0059 Diabetes Mellitus: Hemoglobin A1c Poor Control 2 0064 Diabetes Mellitus: Low Density Lipoprotein (LDL-C) Control 3 0061 Diabetes Mellitus: High Blood Pressure Control 5 0081 Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) T 6 0067 Coronary Artery Disease (CAD): Antiplatelet Therapy 7 0070 Coronary Artery Disease (CAD): Beta-Blocker Therapy- Prior Myocardial Infarction (MI) or Left Ventricu 8 0083 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 9 0105 Major Depressive Disorder (MDD): Antidepressant Medication During Acute Phase for Patients with M 12 0086 Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation 14 0087 Age-Related Macular Degeneration (AMD): Dilated Macular Examination 18 0088 Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity 19 0089 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care 20 0270 Perioperative Care: Timing of Prophylactic Parenteral Antibiotic Ordering Physician 21 0268 Perioperative Care: Selection of Prophylactic Antibiotic First OR Second Generation Cephalosporin 22 0271 Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Non-Cardiac Procedures) 23 0239 Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) 24 0045 Osteoporosis: Communication with the Physician Managing On-going Care Post-Fracture of Hip, Spine 28 0092 Aspirin at Arrival for Acute Myocardial Infarction (AMI) 30 0269 Perioperative Care: Timely Administration of Prophylactic Parenteral Antibiotics 31 0420 Stroke and Stroke Rehabilitation: Deep Vein Thrombosis (DVT) Prophylaxis for Ischemic Stroke or Intra 32 0325 Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy 33 0241 Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation (AF) at Discha 35 0243 Stroke and Stroke Rehabilitation: Screening for Dysphagia 36 0244 Stroke and Stroke Rehabilitation: Rehabilitation Services Ordered 39 0046 Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older 40 0045 Osteoporosis: Management Following Fracture of Hip, Spine or Distal Radius for Men and Women Age 41 0049 Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older 43 0516 Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated 44 0235 Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surger 45 0637 Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Cardiac Procedures) 46 0097 Medication Reconciliation 47 0326 Advance Care Plan 48 0098 Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 49 0099 Urinary Incontinence: Characterization of Urinary Incontinence in Women Aged 65 Years and Older 50 0100 Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older 51 0091 Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation 52 0102 Chronic Obstructive Pulmonary Disease (COPD): Bronchodilator Therapy 53 0047 Asthma: Pharmacologic Therapy for Persistent Asthma Ambulatory Care Setting 54 0090 Emergency Medicine: 12-Lead Electrocardiogram (ECG) Performed for Non-Traumatic Chest Pain 55 0093 Emergency Medicine: 12-Lead Electrocardiogram (ECG) Performed for Syncope 56 0232 Emergency Medicine: Community-Acquired Pneumonia (CAP): Vital Signs 59 0096 Emergency Medicine: Community-Acquired Pneumonia (CAP): Empiric Antibiotic 64 0001 Asthma: Assessment of Asthma Control Ambulatory Care Setting 65 0069 Appropriate Treatment for Children with Upper Respiratory Infection (URI) 66 0002 Appropriate Testing for Children with Pharyngitis 67 0377 Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Pe

68 69 70 71 72 76 81 82 83 84 85 86 87 89 90 91 93 99 100 102 104 106 107 108 109 110 111 112 113 116 117 118 119 121 122 123 126 127 128 130 131 134 137 138 140 141 142

0378 0380 0379 0387 0385 0464 0323 0321 0393 0395 0396 0397 0398 0401 0394 0653 0654 0391 0392 0389 0390 0103 0104 0054 0050 0041 0043 0031 0034 0058 0055 0066 0062 AQA AQA AQA 0417 0416 0421 0419 0420 0418 0650 0561 0566 0563 0051

Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Er Hematology: Multiple Myeloma: Treatment with Bisphosphonates Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry Breast Cancer: Hormonal Therapy for Stage IC - IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients Prevention of Catheter-Related Bloodstream Infections (CRBSI): Central Venous Catheter (CVC) Inserti Adult Kidney Disease: Hemodialysis Adequacy: Solute Adult Kidney Disease: Peritoneal Dialysis Adequacy: Solute Hepatitis C: Testing for Chronic Hepatitis C Confirmation of Hepatitis C Viremia Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment Hepatitis C: HCV Genotype Testing Prior to Treatment Hepatitis C: Antiviral Treatment Prescribed Hepatitis C: HCV Ribonucleic Acid (RNA) Testing at Week 12 of Treatment Hepatitis C: Counseling Regarding Risk of Alcohol Consumption Hepatitis C: Counseling Regarding Use of Contraception Prior to Antiviral Therapy Acute Otitis Externa (AOE): Topical Therapy Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy Avoidance of Inappropriate Use Breast Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regiona Colorectal Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regi Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients Prostate Cancer: Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients Adult Major Depressive Disorder (MDD): Comprehensive Diagnostic Evaluation: Diagnosis and Severity Adult Major Depressive Disorder (MDD): Suicide Risk Assessment Rheumatoid Arthritis (RA): Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy Osteoarthritis (OA): Function and Pain Assessment Preventive Care and Screening: Influenza Immunization Preventive Care and Screening: Pneumococcal Vaccination for Patients 65 Years and Older Preventive Care and Screening: Breast Cancer Screening Preventive Care and Screening: Colorectal Cancer Screening Antibiotic Treatment for Adults with Acute Bronchitis: Avoidance of Inappropriate Use Diabetes Mellitus: Dilated Eye Exam Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Recepto Diabetes: Medical Attention for Nephropathy Adult Kidney Disease: LaboratoryTesting (Lipid Profile) Adult Kidney Disease: Blood Pressure Management Adult Kidney Disease: Patients On Erythropoiesis-Stimulating Agent (ESA) - Hemoglobin Level > 12.0 g/ Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy Neurological Evaluation Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention Evaluation of Footwear Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Documentation of Current Medications in the Medical Record Pain Assessment and Follow-Up Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan Melanoma: Continuity of Care Recall System Melanoma: Coordination of Care Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documenta Osteoarthritis (OA): Assessment for Use of Anti-Inflammatory or Analgesic Over-the-Counter (OTC) Me

143 144 145 146 147 148 149 150 151 154 155 156 157 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 176 177 178 179 180 181 182 183 184 185 *187 188 *191 *192 193 194 195 197 198

0384 0383 0510 0508 0511 0322 0319 0315 0313 AQA AQA 0382 0455 0404 0405 0406 0407 0056 0129 0130 0131 0114 0115 0237 0238 0118 0259 AQA AQA AQA AQA AQA AQA AQA AQA 0399 0400 0659 0437 N/A 0565 0564 0454 0386 0507 0074 0079

Oncology: Medical and Radiation Pain Intensity Quantified Oncology: Medical and Radiation Plan of Care for Pain Radiology: Exposure Time Reported for Procedures Using Fluoroscopy Radiology: Inappropriate Use of Probably Benign Assessment Category in Mammography Screening Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigra Back Pain: Initial Visit Back Pain: Physical Exam Back Pain: Advice for Normal Activities Back Pain: Advice Against Bed Rest Falls: Risk Assessment Falls: Plan of Care Oncology: Radiation Dose Limits to Normal Tissues Thoracic Surgery: Recording of Clinical Stage Prior to Lung Cancer or Esophageal Cancer Resection HIV/AIDS: CD4+ Cell Count or CD4+ Percentage HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Ther HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy Diabetes Mellitus: Foot Exam Coronary Artery Bypass Graft (CABG): Prolonged Intubation Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate Coronary Artery Bypass Graft (CABG): Stroke Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure Coronary Artery Bypass Graft (CABG): Surgical Re-exploration Coronary Artery Bypass Graft (CABG): Antiplatelet Medications at Discharge Coronary Artery Bypass Graft (CABG): Beta-Blockers Administered at Discharge Coronary Artery Bypass Graft (CABG): Anti-Lipid Treatment at Discharge Hemodialysis Vascular Access Decision-Making by Surgeon to Maximize Placement of Autogenous Arte Preventive Care and Screening: Unhealthy Alcohol Use Screening Rheumatoid Arthritis (RA): Tuberculosis Screening Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity Rheumatoid Arthritis (RA): Functional Status Assessment Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis Rheumatoid Arthritis (RA): Glucocorticoid Management Elder Maltreatment Screen and Follow-Up Plan Functional Outcome Assessment Hepatitis C: Hepatitis A Vaccination in Patients with HCV Hepatitis C: Hepatitis B Vaccination in Patients with HCV Endoscopy & Polyp Surveillance: Colonoscopy Interval for Patients with a History of Adenomatous Pol Stroke and Stroke Rehabilitation: Thrombolytic Therapy Referral for Otologic Evaluation for Patients with Congenital or Traumatic Deformity of the Ear Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Proc Perioperative Temperature Management Oncology: Cancer Stage Documented Radiology: Stenosis Measurement in Carotid Imaging Studies Coronary Artery Disease (CAD): Lipid Control Heart Failure: Left Ventricular Ejection Fraction (LVEF) Assessment

201 204 205 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 228 231 232 233 234 236 241 242 243 244 245 246 247 248 249 250 251 252 254 255 256 257 258 259 260

0073 0068 0409 0410 0445 0449 0448 0447 0446 0444 0442 0443 0422 0423 0424 0425 0426 0427 0428 0562 0509 0028 N/A N/A N/A 0457 0458 0018 0075 N/A 0643 N/A AQA AQA AQA AQA N/A N/A N/A 0503 0651 0652 N/A N/A N/A N/A N/A

Ischemic Vascular Disease (IVD): Blood Pressure Management Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia and Gonorrhea HIV/AIDS: Sexually Transmitted Disease Screening for Syphilis Functional Communication Measure - Spoken Language Comprehension Functional Communication Measure - Attention Functional Communication Measure - Memory Functional Communication Measure - Motor Speech Functional Communication Measure - Reading Functional Communication Measure - Spoken Language Expression Functional Communication Measure - Writing Functional Communication Measure - Swallowing Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Knee Impairments Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lower Leg, Foot or Ankl Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lumbar Spine Impairme Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Shoulder Impairments Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Elbow, Wrist or Hand Im Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Neck, Cranium, Mandib Melanoma: Overutilization of Imaging Studies in Melanoma Radiology: Reminder System for Mammograms Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Heart Failure (HF): Left Ventricular Function (LVF) Testing Asthma: Tobacco Use: Screening - Ambulatory Care Setting Asthma: Tobacco Use: Intervention - Ambulatory Care Setting Thoracic Surgery: Recording of Performance Status Prior to Lung or Esophageal Cancer Resection Thoracic Surgery: Pulmonary Function Tests Before Major Anatomic Lung Resection (Pneumonectomy Hypertension (HTN): Controlling High Blood Pressure Ischemic Vascular Disease (IVD): Complete Lipid Panel and Low Density Lipoprotein (LDL-C) Control Coronary Artery Disease (CAD): Symptom Management Cardiac Rehabilitation Patient Referral from an Outpatient Setting Hypertension: Blood Pressure Management Chronic Wound Care: Use of Wound Surface Culture Technique in Patients with Chronic Skin Ulcers (O Chronic Wound Care: Use of Wet to Dry Dressings in Patients with Chronic Skin Ulcers (Overuse Measu Substance Use Disorders: Counseling Regarding Psychosocial and Pharmacologic Treatment Options fo Substance Use Disorders: Screening for Depression Among Patients with Substance Abuse or Depende Barrett's Esophagus Radical Prostatectomy Pathology Reporting Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) Anticoagulation for Acute Pulmonary Embolus Patients Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood Exposure Surveillance after Endovascular Abdominal Aortic Aneurysm Repair (EVAR) Statin Therapy at Discharge after Lower Extremity Bypass (LEB) Rate of Open Repair of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic A Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Disch

261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 317 320 321

N/A N/A N/A N/A 0645 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 0658 0493

Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness Image Confirmation of Successful Excision of ImageLocalized Breast Lesion Preoperative Diagnosis of Breast Cancer Sentinel Lymph Node Biopsy for Invasive Breast Cancer Biopsy Follow-Up Epilepsy: Seizure Type(s) and Current Seizure Frequency(ies) Epilepsy: Documentation of Etiology of Epilepsy or Epilepsy Syndrome Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy Inflammatory Bowel Disease (IBD): Type, Anatomic Location and Activity All Documented Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Sparing Therapy Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury Bone Lo Inflammatory Bowel Disease (IBD): Preventive Care: Influenza Immunization Inflammatory Bowel Disease (IBD): Preventive Care: Pneumococcal Immunization Inflammatory Bowel Disease (IBD): Testing for Latent Tuberculosis (TB) Before Initiating Anti-TNF (Tum Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating AntiSleep Apnea: Assessment of Sleep Symptoms Sleep Apnea: Severity Assessment at Initial Diagnosis Sleep Apnea: Positive Airway Pressure Therapy Prescribed Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy Dementia: Staging of Dementia Dementia: Cognitive Assessment Dementia: Functional Status Assessment Dementia: Neuropsychiatric Symptom Assessment Dementia: Management of Neuropsychiatric Symptoms Dementia: Screening for Depressive Symptoms Dementia: Counseling Regarding Safety Concerns Dementia: Counseling Regarding Risks of Driving Dementia: Caregiver Education and Support Parkinsons Disease: Annual Parkinsons Disease Diagnosis Review Parkinsons Disease: Psychiatric Disorders or Disturbances Assessment Parkinsons Disease: Cognitive Impairment or Dysfunction Assessment Parkinsons Disease: Querying about Sleep Disturbances Parkinsons Disease: Rehabilitative Therapy Options Parkinsons Disease: Parkinsons Disease Medical and Surgical Treatment Options Reviewed Hypertension: Appropriate Use of Aspirin or Other Anththrombotic Therapy Hypertension: Complete Lipid Profile Hypertension: Urine Protein Test Hypertension: Annual Serum Creatinine Test Hypertension: Diabetes Mellitus Screening Test Hypertension: Blood Pressure Control Hypertension: Low Density Lipoprotein (LDL-C) Control Hypertension: Dietary and Physical Activity Modifications Appropriately Prescribed Cataracts: Improvement in Patients Visual Function within 90 Days Following Cataract Surgery Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented Endoscopy/Polyp Surveillance: Appropriate Follow-Up Interval for Normal Colonoscopy in Average Ris Participation by a Hospital, Physician or Other Clinician in a Systematic Clinical Database Registry that

322 323 324 325 326 327 328

0670 0671 0672 N/A 1525 N/A 1667

Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surg Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coro Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asyptomatic, Low-Risk Patient Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Comorbid Conditions Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy Pediatric Kidney Disease: Adequacy of Volume Management Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dL

iotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

dial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) unction (LVSD) g Acute Phase for Patients with MDD

cular Edema and Level of Severity of Retinopathy Ongoing Diabetes Care dering Physician cond Generation Cephalosporin iotics (Non-Cardiac Procedures) hen Indicated in ALL Patients) g Care Post-Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older

Antibiotics hylaxis for Ischemic Stroke or Intracranial Hemorrhage

or Atrial Fibrillation (AF) at Discharge

l Radius for Men and Women Aged 50 Years and Older Years and Older ry (IMA) in Patients with Isolated CABG Surgery atients with Isolated CABG Surgery iotics (Cardiac Procedures)

Incontinence in Women Aged 65 Years and Older omen Aged 65 Years and Older en Aged 65 Years and Older

Care Setting or Non-Traumatic Chest Pain

ic Antibiotic

s: Baseline Cytogenetic Testing Performed on Bone Marrow

on Stores in Patients Receiving Erythropoietin Therapy

or/Progesterone Receptor (ER/PR) Positive Breast Cancer

tral Venous Catheter (CVC) Insertion Protocol

is C Viremia

viral Therapy

nce of Inappropriate Use Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade ary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade Risk Prostate Cancer Patients Cancer Patients Evaluation: Diagnosis and Severity

DMARD) Therapy

nts 65 Years and Older

nappropriate Use

E) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)

ESA) - Hemoglobin Level > 12.0 g/dL thy Neurological Evaluation Evaluation of Footwear d Follow-Up

Follow-Up Plan

nt Supplement ssure (IOP) by 15% OR Documentation of a Plan of Care lgesic Over-the-Counter (OTC) Medications

gory in Mammography Screening atients Undergoing Bone Scintigraphy

Esophageal Cancer Resection

scribed Potent Antiretroviral Therapy

ize Placement of Autogenous Arterial Venous (AV) Fistula

ith a History of Adenomatous Polyps Avoidance of Inappropriate Use

matic Deformity of the Ear taract Surgery Requiring Additional Surgical Procedures

Gonorrhea

ents with Knee Impairments ents with Hip Impairments ents with Lower Leg, Foot or Ankle Impairments ents with Lumbar Spine Impairments ents with Shoulder Impairments ents with Elbow, Wrist or Hand Impairments ents with Neck, Cranium, Mandible, Thoracic Spine, Ribs, or Other General Orthopedic Impairments

n Intervention

Esophageal Cancer Resection Lung Resection (Pneumonectomy, Lobectomy, or Formal Segmentectomy)

ity Lipoprotein (LDL-C) Control

tients with Chronic Skin Ulcers (Overuse Measure) hronic Skin Ulcers (Overuse Measure) armacologic Treatment Options for Alcohol Dependence with Substance Abuse or Dependence

Factor Receptor 2 Testing (HER2) for Breast Cancer Patients

nts with Abdominal Pain Risk of Fetal Blood Exposure

Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2) thout Major Complications (Discharged to Home Post-Operative Day #2)

ivity All Documented paring Therapy elated Iatrogenic Injury Bone Loss Assessment

mmunization B) Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy

ment Options Reviewed

ely Prescribed Following Cataract Surgery

d Follow-Up Documented ormal Colonoscopy in Average Risk Patients ic Clinical Database Registry that Includes Consensus Endorsed Quality

erative Evaluation in Low Risk Surgery Patients e Testing After Percutaneous Coronary Intervention (PCI) g in Asyptomatic, Low-Risk Patients ients with Comorbid Conditions

bin Level < 10 g/dL

ction (LVEF < 40%)

y Post-Operative Day #2)

----------------------(NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (NOTE: A lower performance rate is desirable for this measure) (Note: Measures poor control. A lower performance rate indicates better control.) 0509F 0517F & 3285F 0518F 0520F 0521F 0528F 0529F 1006F 1007F 1010F & 1011F & 0557F 1010F & 1012F 1011F & 0557F 1012F 1031F 1036F 1040F & G8930 1090F 1091F 1111F 1123F 1124F 1125F 1126F 1130F 1170F 1175F 1181F 1200F 1205F 1220F 1400F 1490F

G8868 G8924 G8702 G8463 G8465 G8397 G0908 G0913 G0916 G0920 G8126 G8399 G8404 G8410 G8417 G8418 G8420 G8427 G8431 G8450 G8450 & G8923 G8473 G8476 G8477 & 0513F G8482 G8506 G8510 G8530 G8539 G8542 G8556 G8569 G8571 G8573 G8575 G8577 G8579 G8582 G8585 G8588 & G8590 G8593 & G8595 G8598 G8600 G8603 G8606 G8609 G8612

1491F 1493F 1494F 2010F 2015F & 2016F 2019F 2021F 2022F 2024F 2026F 2027F 2028F 2040F 3014F 3016F 3017F 3023F 3038F 3046F 3046F-8P 3048F 3060F 3061F 3062F 3066F 3072F 3095F 3096F 3100F 3120F 3125F 3155F 3160F & 4090F 3170F 3210F & G8711 3215F 3216F 3218F & 4150F 3220F & G8461 3260F 3265F 3266F & G8459 3267F 3270F & 3271F 3284F 3288F & 1100F 3300F

G8615 G8618 G8621 G8624 G8627 G8629 G8630 G8633 G8647 G8648 G8651 G8652 G8655 G8656 G8659 G8660 G8663 G8664 G8667 G8668 G8671 G8672 G8682 G8696 G8699 G8704 G8708 G8713 G8718 G8721 G8725 G8730 G8731 G8733 G8734 G8736 G8737 & 4013F & 0556F G8738 G8739 G8752 & G8754 G8767 G8770 G8771 G8774 G8777 G8780 G8783

3301F 3320F 3323F 3328F 3343F 3394F 3455F & 4195F 3470F 3471F 3472F 3475F 3476F 3500F 3502F 3502F & 4270F 3503F & 0575F 3503F & 0575F & 4270F 3510F & G8868 3511F 3512F 3517F 3570F 3700F 3720F 3725F 4000F & 1032F 4001F & 1032F 4004F 4005F 4008F 4008F 4010F 4010F & 3021F 4025F & G8924 4035F 4037F 4040F 4041F 4043F & G8702 4044F 4045F 4048F 4049F & 4046F 4070F 4075F 4084F 4086F

G8790 & G8793 G8790 & G8794 G8790 & G8795 & 4145F G8791 & G8793 G8791 & G8794 G8791 & G8795 & 4145F G8792 & G8793 & 4145F G8792 & G8794 & 4145F G8792 & G8795 & 4145F G8799 G8806 G8809 G8813 G8816 G8818 G8826 G8834 G8839 G8842 G8845 & G8846 G8851 & G8852 G8856 G8859 & 4142F G8860 & G8861 G8864 G8869 G8870 G8872 G8875 G8878 G8883 G8886 G8890 G8895 G8919 & G8921 G8927 & 3388F G8932 G8935 G8942 G8947 & 4525F G8947 & 4526F G8950 G8954 G8955 & G8956 G8959 G8961 G8963

4100F 4110F 4115F 4124F 4130F 4132F 4140F & 1038F 4144F & 1038F 4148F 4149F 4153F 4158F 4159F & G8463 4164F & G8465 4175F 4177F 4179F & 3374F & 3315F 4179F & 3376F & 3315F 4179F & 3378F & 3315F 4187F 4192F 4193F 4194F & 0540F 4245F 4248F 4250F & 4255F 4261F 4266F 4276F 4276F & 3490F 4276F & 3492F 4280F 4280F & 3494F 4320F 4322F 4325F 4328F 4340F 4400F 4500F 5010F & G8397 5015F 5050F 6010F & 6015F 6030F 6045F 6101F

G8965 G8967 & G8972 G8973 Meets Performance

6102F 6110F 6150F 7010F 7025F G0908 G0913 G0916 G0920 G8126 G8399 G8404 G8410 G8417 G8418 G8420 G8427 G8431 G8450 G8450 & G8923 G8473 G8476 G8477 & 0513F G8482 G8506 G8510 G8530 G8539 G8542 G8556 G8569 G8571 G8573 G8575 G8577 G8579 G8582 G8585 G8588 & G8590 G8593 & G8595 G8598 G8600 G8603 G8606 G8609 G8612 G8615

G8618 G8621 G8624 G8627 G8629 G8630 G8633 G8647 G8648 G8651 G8652 G8655 G8656 G8659 G8660 G8663 G8664 G8667 G8668 G8671 G8672 G8682 G8696 G8699 G8704 G8708 G8713 G8718 G8721 G8725 G8730 G8731 G8733 G8734 G8736 G8737 & 4013F & 0556F G8738 G8739 G8752 & G8754 G8767 G8770 G8771 G8774 G8777 G8780 G8783 G8790 & G8793

G8790 & G8794 G8790 & G8795 & 4145F G8791 & G8793 G8791 & G8794 G8791 & G8795 & 4145F G8792 & G8793 & 4145F G8792 & G8794 & 4145F G8792 & G8795 & 4145F G8799 G8806 G8809 G8813 G8816 G8818 G8826 G8834 G8839 G8842 G8845 & G8846 G8851 & G8852 G8856 G8859 & 4142F G8860 & G8861 G8864 G8869 G8870 G8872 G8875 G8878 G8883 G8886 G8890 G8895 G8919 & G8921 G8927 & 3388F G8932 G8935 G8942 G8947 & 4525F G8947 & 4526F G8950 G8954 G8955 & G8956 G8959 G8961 G8963 G8965

G8967 & G8972 G8973 Meets Performance

013F & 0556F

8795 & 4145F

8795 & 4145F 8793 & 4145F 8794 & 4145F 8795 & 4145F

PQRS Number 1

*5 *5

6 *7

*8 *8

9 12 14 18 19 20 21 22 23 24 28 30 31 32 *33

35 36 39 40

41 43 44 45 46 47 48 49 50 51 52

53 54 55

56 59 64 65 66 67 68 69 70 71

72

76 *81 *82 *83 84 85 86 87 89 90 91 93 99 100

102

104 106 107 108 109 110

111 112

113 116 117

*118

119

121 122 123

126 127 128

130 131

134

*137 *138 140 141 142 *143 *144

145 146

147 148 149 150 151 154

155 156 157 *159 *160 *160

*161 *161 *162 *162 163 *164 *165 *166 *167 *168 *169

*170 *171 172 173 176 177

178 179 180

181

182

183 184 185 *187 188 *191 *192 193 194 195 *197

*198 201

204 *205 *208 *209 *210 *211 *212 *213 *214 *215 *216 *217 *218 *219 *220 221 *222 *223 *224 225 226 *228 231 232

*233

*234 236

241 242* 242* 243* 244*

245 246 247 248 249 250 251 252 254 255 256* 257* 258* 259* 260* 261

262 263

264* 265* 266 267 268 269* 270* 271* 272* 273*

274* 275*

276* 277* 278*

279*

280*

281* 282* 283* 284* 285* 286*

287* 288* 289* 290* 291* 292* 293* 294* 295* 296* 297* 298* 299* 300* 301*

302*

303* 304* 317

320 321 322* 323* 324* 325* 326

327 328

PQRS Number NQF Number Measure Title & Description

1 2 3 5 6 7 8 9 12 14 18 19 20 21 22 23 24 28 30 31 32 33 35 36 39 40 41 43 44 45 46 47 48 49 50 51 52 53 54 55 56 59 64 65 66 59 64 61 81 67 70 83 105 86 87 88 89 270 268 271 239 45 92 269 420 325 241 243 244 46 45 49 516 235 637 97 326 98 99 100 91 102 47 90 93 232 96 1 69 2

Diabetes Mellitus: Hemoglobin A1c Poor Control Diabetes Mellitus: Low Density Lipoprotein (LDL-C) Control Diabetes Mellitus: High Blood Pressure Control Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker Coronary Artery Disease (CAD): Antiplatelet Therapy Coronary Artery Disease (CAD): Beta-Blocker Therapy- Prior Myocardial Infarction (MI) or Left Individual Measures Reporting: Heart Failure: Beta-Blocker Therapy for Left Ventricular Systoli Major Depressive Disorder (MDD): Antidepressant Medication During Acute Phase for Patients Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation Age-Related Macular Degeneration (AMD): Dilated Macular Examination Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care Perioperative Care: Timing of Prophylactic Parenteral Antibiotic Ordering Physician Perioperative Care: Selection of Prophylactic Antibiotic First OR Second Generation Cephalos Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Non-Cardiac Proced Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patie Osteoporosis: Communication with the Physician Managing On-going Care Post-Fracture of Hip Aspirin at Arrival for Acute Myocardial Infarction (AMI) Perioperative Care: Timely Administration of Prophylactic Parenteral Antibiotics Stroke and Stroke Rehabilitation: Deep Vein Thrombosis (DVT) Prophylaxis for Ischemic Stroke Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation (AF) a Stroke and Stroke Rehabilitation: Screening for Dysphagia Stroke and Stroke Rehabilitation: Rehabilitation Services Ordered Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older Osteoporosis: Management Following Fracture of Hip, Spine or Distal Radius for Men and Wom Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with I Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Cardiac Procedures Medication Reconciliation Advance Care Plan Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women A Urinary Incontinence: Characterization of Urinary Incontinence in Women Aged 65 Years and O Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Olde Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation Chronic Obstructive Pulmonary Disease (COPD): Bronchodilator Therapy Asthma: Pharmacologic Therapy for Persistent Asthma Ambulatory Care Setting Emergency Medicine: 12-Lead Electrocardiogram (ECG) Performed for Non-Traumatic Chest Pa Emergency Medicine: 12-Lead Electrocardiogram (ECG) Performed for Syncope Emergency Medicine: Community-Acquired Pneumonia (CAP): Vital Signs Emergency Medicine: Community-Acquired Pneumonia (CAP): Empiric Antibiotic Asthma: Assessment of Asthma Control Ambulatory Care Setting Appropriate Treatment for Children with Upper Respiratory Infection (URI) Appropriate Testing for Children with Pharyngitis

67 68 69 70 71 72 76 *81 *82 *83 84 85 86 87 89 90 91 93 99 100 102 104 106 107 108 109 110 111 112 113 116 117 118 119 121 122 123 126 127 128 130 131 134 137 138 140 141

377 378 380 379 387 385 464 323 321 393 395 396 397 398 401 394 653 654 391 392 389 390 103 104 54 50 41 43 31 34 58 55 66 62 AQA AQA AQA 417 416 421 419 420 418 650 561 566 563

Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Te Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Rece Hematology: Multiple Myeloma: Treatment with Bisphosphonates Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry Breast Cancer: Hormonal Therapy for Stage IC - IIIC Estrogen Receptor/Progesterone Receptor Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients Prevention of Catheter-Related Bloodstream Infections (CRBSI): Central Venous Catheter (CVC Adult Kidney Disease: Hemodialysis Adequacy: Solute Adult Kidney Disease: Peritoneal Dialysis Adequacy: Solute Hepatitis C: Testing for Chronic Hepatitis C Confirmation of Hepatitis C Viremia Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment Hepatitis C: HCV Genotype Testing Prior to Treatment Hepatitis C: Antiviral Treatment Prescribed Hepatitis C: HCV Ribonucleic Acid (RNA) Testing at Week 12 of Treatment Hepatitis C: Counseling Regarding Risk of Alcohol Consumption Hepatitis C: Counseling Regarding Use of Contraception Prior to Antiviral Therapy Acute Otitis Externa (AOE): Topical Therapy Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy Avoidance of Inappropriate Use Breast Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category ( Colorectal Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Catego Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Pati Prostate Cancer: Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients Adult Major Depressive Disorder (MDD): Comprehensive Diagnostic Evaluation: Diagnosis and Adult Major Depressive Disorder (MDD): Suicide Risk Assessment Rheumatoid Arthritis (RA): Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy Osteoarthritis (OA): Function and Pain Assessment Preventive Care and Screening: Influenza Immunization Preventive Care and Screening: Pneumococcal Vaccination for Patients 65 Years and Older Preventive Care and Screening: Breast Cancer Screening Preventive Care and Screening: Colorectal Cancer Screening Antibiotic Treatment for Adults with Acute Bronchitis: Avoidance of Inappropriate Use Diabetes Mellitus: Dilated Eye Exam Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Diabetes: Medical Attention for Nephropathy Adult Kidney Disease: LaboratoryTesting (Lipid Profile) Adult Kidney Disease: Blood Pressure Management Adult Kidney Disease: Patients On Erythropoiesis-Stimulating Agent (ESA) - Hemoglobin Level > Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy Neurological Evaluat Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention Evaluation of Footwear Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Documentation of Current Medications in the Medical Record Pain Assessment and Follow-Up Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan Melanoma: Continuity of Care Recall System Melanoma: Coordination of Care Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Doc

142 *143 *144 145 146 147 148 149 150 151 154 155 156 157 *159 *160 *160 *161 *161 *162 *162 163 *164 *165 *166 *167 *168 *169 *170 *171 172 173 176 177 178 179 180 181 182 183 184 185 *187 188 *191 *192 193

51 384 383 510 508 511 322 319 315 313 AQA AQA 382 455 404 405 405 406 406 407 407 56 129 130 131 114 115 237 238 118 259 AQA AQA AQA AQA AQA AQA AQA AQA 399 400 659 437 N/A 565 564 454

Osteoarthritis (OA): Assessment for Use of Anti-Inflammatory or Analgesic Over-the-Counter (O Oncology: Medical and Radiation Pain Intensity Quantified Oncology: Medical and Radiation Plan of Care for Pain Radiology: Exposure Time Reported for Procedures Using Fluoroscopy Radiology: Inappropriate Use of Probably Benign Assessment Category in Mammography Scr Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone S Back Pain: Initial Visit Back Pain: Physical Exam Back Pain: Advice for Normal Activities Back Pain: Advice Against Bed Rest Falls: Risk Assessment Falls: Plan of Care Oncology: Radiation Dose Limits to Normal Tissues Thoracic Surgery: Recording of Clinical Stage Prior to Lung Cancer or Esophageal Cancer Resect HIV/AIDS: CD4+ Cell Count or CD4+ Percentage Individual Measures Reporting: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis Measures Group Reporting: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis Individual Measures Reporting: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who A Measures Group Reporting: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are P Individual Measures Reporting: HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretr Measures Group Reporting: HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretrovir Diabetes Mellitus: Foot Exam Coronary Artery Bypass Graft (CABG): Prolonged Intubation Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate Coronary Artery Bypass Graft (CABG): Stroke Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure Coronary Artery Bypass Graft (CABG): Surgical Re-exploration Coronary Artery Bypass Graft (CABG): Antiplatelet Medications at Discharge Coronary Artery Bypass Graft (CABG): Beta-Blockers Administered at Discharge Coronary Artery Bypass Graft (CABG): Anti-Lipid Treatment at Discharge Hemodialysis Vascular Access Decision-Making by Surgeon to Maximize Placement of Autogen Preventive Care and Screening: Unhealthy Alcohol Use Screening Rheumatoid Arthritis (RA): Tuberculosis Screening Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity Rheumatoid Arthritis (RA): Functional Status Assessment Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis Rheumatoid Arthritis (RA): Glucocorticoid Management Elder Maltreatment Screen and Follow-Up Plan Functional Outcome Assessment Hepatitis C: Hepatitis A Vaccination in Patients with HCV Hepatitis C: Hepatitis B Vaccination in Patients with HCV Endoscopy & Polyp Surveillance: Colonoscopy Interval for Patients with a History of Adenomat Stroke and Stroke Rehabilitation: Thrombolytic Therapy Referral for Otologic Evaluation for Patients with Congenital or Traumatic Deformity of the Ear Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgic Perioperative Temperature Management

194 195 *197 *198 201 204 *205 *208 *209 *210 *211 *212 *213 *214 *215 *216 *217 *218 *219 *220 221 *222 *223 *224 225 226 *228 231 232 *233 *234 236 241 242* 242* 243* 244* 245 246 247 248 249 250 251 252 254 255

386 507 74 79 73 68 409 410 445 449 448 447 446 444 442 443 422 423 424 425 426 427 428 562 509 28 N/A N/A N/A 457 458 18 75 N/A N/A 643 N/A AQA AQA AQA AQA N/A N/A N/A 503 651 652

Oncology: Cancer Stage Documented Radiology: Stenosis Measurement in Carotid Imaging Studies Coronary Artery Disease (CAD): Lipid Control Heart Failure: Left Ventricular Ejection Fraction (LVEF) Assessment Ischemic Vascular Disease (IVD): Blood Pressure Management Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia and Gonorrhea HIV/AIDS: Sexually Transmitted Disease Screening for Syphilis Functional Communication Measure - Spoken Language Comprehension Functional Communication Measure - Attention Functional Communication Measure - Memory Functional Communication Measure - Motor Speech Functional Communication Measure - Reading Functional Communication Measure - Spoken Language Expression Functional Communication Measure - Writing Functional Communication Measure - Swallowing Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Knee Impairmen Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairment Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lower Leg, Foot Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lumbar Spine Im Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Shoulder Impair Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Elbow, Wrist or Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Neck, Cranium, Melanoma: Overutilization of Imaging Studies in Melanoma Radiology: Reminder System for Mammograms Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Heart Failure (HF): Left Ventricular Function (LVF) Testing Asthma: Tobacco Use: Screening - Ambulatory Care Setting Asthma: Tobacco Use: Intervention - Ambulatory Care Setting Thoracic Surgery: Recording of Performance Status Prior to Lung or Esophageal Cancer Resecti Thoracic Surgery: Pulmonary Function Tests Before Major Anatomic Lung Resection (Pneumon Hypertension (HTN): Controlling High Blood Pressure Ischemic Vascular Disease (IVD): Complete Lipid Panel and Low Density Lipoprotein (LDL-C) Con Individual Reporting via Registry: Coronary Artery Disease (CAD): Symptom Management Measures Group Reporting: Coronary Artery Disease (CAD): Symptom Management Cardiac Rehabilitation Patient Referral from an Outpatient Setting Hypertension: Blood Pressure Management Chronic Wound Care: Use of Wound Surface Culture Technique in Patients with Chronic Skin U Chronic Wound Care: Use of Wet to Dry Dressings in Patients with Chronic Skin Ulcers (Overus Substance Use Disorders: Counseling Regarding Psychosocial and Pharmacologic Treatment Op Substance Use Disorders: Screening for Depression Among Patients with Substance Abuse or D Barrett's Esophagus Radical Prostatectomy Pathology Reporting Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing Anticoagulation for Acute Pulmonary Embolus Patients Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood Exposur

256* 257* 258* 259* 260* 261 262 263 264* 265* 266 267 268 269* 270* 271* 272* 273* 274* 275* 276* 277* 278* 279* 280* 281* 282* 283* 284* 285* 286* 287* 288* 289* 290* 291* 292* 293* 294* 295* 296* 297* 298* 299* 300* 301* 302*

N/A N/A N/A N/A N/A N/A N/A N/A N/A 645 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

Surveillance after Endovascular Abdominal Aortic Aneurysm Repair (EVAR) Statin Therapy at Discharge after Lower Extremity Bypass (LEB) Rate of Open Repair of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) w Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complication Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness Image Confirmation of Successful Excision of ImageLocalized Breast Lesion Preoperative Diagnosis of Breast Cancer Sentinel Lymph Node Biopsy for Invasive Breast Cancer Biopsy Follow-Up Epilepsy: Seizure Type(s) and Current Seizure Frequency(ies) Epilepsy: Documentation of Etiology of Epilepsy or Epilepsy Syndrome Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy Inflammatory Bowel Disease (IBD): Type, Anatomic Location and Activity All Documented Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Sparing Therapy Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury Inflammatory Bowel Disease (IBD): Preventive Care: Influenza Immunization Inflammatory Bowel Disease (IBD): Preventive Care: Pneumococcal Immunization Inflammatory Bowel Disease (IBD): Testing for Latent Tuberculosis (TB) Before Initiating Anti-T Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiati Sleep Apnea: Assessment of Sleep Symptoms Sleep Apnea: Severity Assessment at Initial Diagnosis Sleep Apnea: Positive Airway Pressure Therapy Prescribed Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy Dementia: Staging of Dementia Dementia: Cognitive Assessment Dementia: Functional Status Assessment Dementia: Neuropsychiatric Symptom Assessment Dementia: Management of Neuropsychiatric Symptoms Dementia: Screening for Depressive Symptoms Dementia: Counseling Regarding Safety Concerns Dementia: Counseling Regarding Risks of Driving Dementia: Caregiver Education and Support Parkinsons Disease: Annual Parkinsons Disease Diagnosis Review Parkinsons Disease: Psychiatric Disorders or Disturbances Assessment Parkinsons Disease: Cognitive Impairment or Dysfunction Assessment Parkinsons Disease: Querying about Sleep Disturbances Parkinsons Disease: Rehabilitative Therapy Options Parkinsons Disease: Parkinsons Disease Medical and Surgical Treatment Options Reviewed Hypertension: Appropriate Use of Aspirin or Other Anththrombotic Therapy Hypertension: Complete Lipid Profile Hypertension: Urine Protein Test Hypertension: Annual Serum Creatinine Test Hypertension: Diabetes Mellitus Screening Test Hypertension: Blood Pressure Control Hypertension: Low Density Lipoprotein (LDL-C) Control Hypertension: Dietary and Physical Activity Modifications Appropriately Prescribed

303* 304* 317 320 321 322* 323* 324* 325* 326 327 328

N/A N/A N/A 658 493 670 671 672 N/A 1525 N/A 1667

Cataracts: Improvement in Patients Visual Function within 90 Days Following Cataract Surgery Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented Endoscopy/Polyp Surveillance: Appropriate Follow-Up Interval for Normal Colonoscopy in Aver Participation by a Hospital, Physician or Other Clinician in a Systematic Clinical Database Regist Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low R Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneo Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asyptomatic, Low-Risk Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Comorbid Cond Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy Pediatric Kidney Disease: Adequacy of Volume Management Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dL

Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

cardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) apy for Left Ventricular Systolic Dysfunction (LVSD) uring Acute Phase for Patients with MDD

Macular Edema and Level of Severity of Retinopathy ing Ongoing Diabetes Care Ordering Physician R Second Generation Cephalosporin ntibiotics (Non-Cardiac Procedures) s (When Indicated in ALL Patients) going Care Post-Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older

teral Antibiotics rophylaxis for Ischemic Stroke or Intracranial Hemorrhage

bed for Atrial Fibrillation (AF) at Discharge

s and Older Distal Radius for Men and Women Aged 50 Years and Older d 50 Years and Older Artery (IMA) in Patients with Isolated CABG Surgery in Patients with Isolated CABG Surgery ntibiotics (Cardiac Procedures)

nary Incontinence in Women Aged 65 Years and Older n Women Aged 65 Years and Older omen Aged 65 Years and Older

atory Care Setting ed for Non-Traumatic Chest Pain ed for Syncope

mpiric Antibiotic

mias: Baseline Cytogenetic Testing Performed on Bone Marrow of Iron Stores in Patients Receiving Erythropoietin Therapy

w Cytometry eptor/Progesterone Receptor (ER/PR) Positive Breast Cancer

Central Venous Catheter (CVC) Insertion Protocol

patitis C Viremia

Antiviral Therapy

oidance of Inappropriate Use ary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade Low Risk Prostate Cancer Patients ate Cancer Patients stic Evaluation: Diagnosis and Severity

ug (DMARD) Therapy

atients 65 Years and Older

e of Inappropriate Use

(ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)

ent (ESA) - Hemoglobin Level > 12.0 g/dL ropathy Neurological Evaluation n Evaluation of Footwear g and Follow-Up

and Follow-Up Plan

xidant Supplement Pressure (IOP) by 15% OR Documentation of a Plan of Care

Analgesic Over-the-Counter (OTC) Medications

Category in Mammography Screening All Patients Undergoing Bone Scintigraphy

r or Esophageal Cancer Resection

Pneumonia (PCP) Prophylaxis eumonia (PCP) Prophylaxis Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy ents with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy Six Months of Potent Antiretroviral Therapy Months of Potent Antiretroviral Therapy

t Discharge ed at Discharge

aximize Placement of Autogenous Arterial Venous (AV) Fistula

ase Prognosis

ts with a History of Adenomatous Polyps Avoidance of Inappropriate Use

raumatic Deformity of the Ear g Cataract Surgery ery Requiring Additional Surgical Procedures

and Gonorrhea

Patients with Knee Impairments Patients with Hip Impairments Patients with Lower Leg, Foot or Ankle Impairments Patients with Lumbar Spine Impairments Patients with Shoulder Impairments Patients with Elbow, Wrist or Hand Impairments Patients with Neck, Cranium, Mandible, Thoracic Spine, Ribs, or Other General Orthopedic Impairments

sation Intervention

or Esophageal Cancer Resection mic Lung Resection (Pneumonectomy, Lobectomy, or Formal Segmentectomy)

Density Lipoprotein (LDL-C) Control : Symptom Management ptom Management

n Patients with Chronic Skin Ulcers (Overuse Measure) th Chronic Skin Ulcers (Overuse Measure) d Pharmacologic Treatment Options for Alcohol Dependence nts with Substance Abuse or Dependence

wth Factor Receptor 2 Testing (HER2) for Breast Cancer Patients

atients with Abdominal Pain at Risk of Fetal Blood Exposure

minal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) rate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2) s, without Major Complications (Discharged to Home Post-Operative Day #2) ic Dizziness east Lesion

Activity All Documented oid Sparing Therapy oid Related Iatrogenic Injury Bone Loss Assessment mmunization cal Immunization is (TB) Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy us (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy

ure Therapy

eatment Options Reviewed tic Therapy

priately Prescribed

ays Following Cataract Surgery

e and Follow-Up Documented or Normal Colonoscopy in Average Risk Patients ematic Clinical Database Registry that Includes Consensus Endorsed Quality eoperative Evaluation in Low Risk Surgery Patients utine Testing After Percutaneous Coronary Intervention (PCI) sting in Asyptomatic, Low-Risk Patients Patients with Comorbid Conditions

oglobin Level < 10 g/dL

sfunction (LVEF < 40%)

me by Post-Operative Day #2)

PQRS Number NQF Number Measure Title Meets & Description Performance Medical Performance Patient Performance System Performance Other Performance Performance Exclusion Exclusion Exclusion Exclusion Not Met 1 0059 Diabetes Mellitus: 3046F Hemoglobin N/A A1c N/A Poor Control N/A No Report 3044F 3046F-8P 3045F (Note: Measures poor control. A lower performance rate indicates better control.) 2 0064 Diabetes Mellitus: 3048F Low N/A Density Lipoprotein N/A (LDL-C) N/A Control No Report 3049F 3050F 3048F-8P 3 0061 Diabetes Mellitus: G8919 & High G8921 N/A Blood Pressure N/A Control N/A No Report G8919 & G8922 G8920 & G8921 G8920 & G8922 2000F-8P *5 0081 Individual Measures 4010F Reporting: 4010F-1P Heart 4010F-2P Failure: Angiotensin-Converting 4010F-3P No Report 4010F-8P Enzyme (ACE) Inhibitor or Angio *5 0081 Measures Group 4010FReporting: & 3021F 4010F-1P Heart &Failure: 4010F-2P 3021F Angiotensin-Converting &4010F-3P 3021F &3022F 3021F Enzyme 4010F-8P (ACE) & Inhibitor 3021F or Angioten 3021F-8P No Report 6 0067 Coronary Artery 4086F Disease 4086F-1P (CAD): Antiplatelet 4086F-2P Therapy 4086F-3P No Report 4086F-8P *7 0070 Coronary Artery 4008F Disease 4008F-1P (CAD): Beta-Blocker 4008F-2P Therapy4008F-3P Prior NoMyocardial Report 4008F-8P Infarction (MI) or Left Ventricu ------------ ------------ ------------ ------------ ------------ -----------4008F 4008F-1P 4008F-2P 4008F-3P No Report 4008F-8P *8 0083 Individual Measures G8450 Reporting: N/A Heart N/A Failure: Beta-Blocker N/A G8451 Therapy for G8452 Left Ventricular Systolic Dysfun No Report *8 0083 Measures Group G8450 Reporting: & G8923 N/A Heart Failure: N/A Beta-Blocker N/A Therapy G8541 for Left G8452 Ventricular Systolic Dysfunctio G8395 G8923 G8396 No Report 9 0105 Major Depressive G8126Disorder N/A (MDD):N/A Antidepressant N/A Medication G8128 During G8127 Acute Phase for Patients with M No Report 12 0086 Primary Open 2027F Angle Glaucoma 2027F-1P (POAG): N/A Optic Nerve N/A Evaluation No Report 2027F-8P 14 0087 Age-Related 2019F Macular Degeneration 2019F-1P 2019F-2P (AMD): Dilated N/A Macular NoExamination Report 2019F-8P 18 0088 Diabetic Retinopathy: 2021F Documentation 2021F-1P 2021F-2P of Presence N/A or Absence No Report of Macular 2021F-8P Edema and Level of Severity 19 0089 Diabetic Retinopathy: 5010F & G8397 Communication 5010F-1P &5010F-2P G8397 with the &N/A G8397 Physician Managing G8398 Ongoing 5010F-8P Diabetes & G8397 Care No Report 20 0270 Perioperative G8629 Care: Timing N/A of Prophylactic N/A Parenteral N/A Antibiotic G8631 Ordering G8632Physician G8630 No Report 21 0268 Perioperative 4041F Care: Selection 4041F-1P of Prophylactic N/A Antibiotic N/A First No Report OR Second 4041F-8P Generation Cephalosporin 22 0271 Perioperative 4049F Care: &Discontinuation 4046F 4049F-1P &N/A 4046F of Prophylactic N/A Parenteral 4042F Antibiotics 4049F-8P (Non-Cardiac & 4046F Procedures) No Report 23 0239 Perioperative 4044F Care: Venous 4044F-1P Thromboembolism N/A N/A (VTE) Prophylaxis No Report (When 4044F-8P Indicated in ALL Patients) 24 0045 Osteoporosis: 5015F Communication 5015F-1P with 5015F-2P the Physician N/AManaging NoOn-going Report 5015F-8P Care Post-Fracture of Hip, Spine 28 0092 Aspirin at Arrival 4084Ffor Acute 4084F-1P Myocardial 4084F-2P Infarction N/A (AMI) No Report 4084F-8P 30 0269 Perioperative 4048F Care: Timely 4048F-1P Administration N/A of Prophylactic N/A 4047F-8P Parenteral 4048F-8P Antibiotics No Report 31 0420 Stroke and Stroke 4070F Rehabilitation: 4070F-1P Deep 4070F-2P Vein Thrombosis N/A (DVT) No Report Prophylaxis 4070F-8P for Ischemic Stroke or Intra 32 0325 Stroke and Stroke G8696 Rehabilitation: N/A Discharged N/A on N/A Antithrombotic G8697 Therapy G8698 No Report *33 0241 Stroke and Stroke 4075F Rehabilitation: 4075F-1P Anticoagulant 4075F-2P N/A Therapy Prescribed No Report for 4075F-8P Atrial Fibrillation (AF) at Discha

35 36 39 40

0243 0244 0046 0045

41 43 44 45 46 47 48 49 50 51 52

0049 0516 0235 0637 0097 0326 0098 0099 0100 0091 0102

53 54 55

0047 0090 0093

56 59 64 65 66 67 68 69 70 71

0232 0096 0001 0069 0002 0377 0378 0380 0379 0387

Stroke and Stroke 6010F & Rehabilitation: 6015F 6010F-1P & Screening 6010F-2P 6015F for &N/A 6015F Dysphagia6020F 6010F-8P & 6015F No Report Stroke and Stroke G8699 Rehabilitation: N/A Rehabilitation N/A N/A Services Ordered G8700 G8701 No Report Screening or G8399 Therapy for N/A Osteoporosis N/A for Women N/A Aged 65 G8401 Years andG8400 Older No Report Osteoporosis: 3096F Management 3096F-1P Following 3096F-2P Fracture 3096F-3P of Hip, Spine G8634 or Distal3096F-8P Radius for Men and Women Age 3095F 3095F-1P 3095F-2P 3095F-3P No Report 3095F-8P G8633 G8635 Osteoporosis: 4005F Pharmacologic 4005F-1P Therapy 4005F-2P for Men 4005F-3P and Women NoAged Report 50 Years 4005F-8P and Older Coronary Artery 4110F Bypass4110F-1P Graft (CABG): N/AUse of Internal N/A Mammary No Report Artery 4110F-8P (IMA) in Patients with Isolated Coronary Artery 4115F Bypass4115F-1P Graft (CABG): N/APreoperative N/A Beta-Blocker No Report in Patients 4115F-8P with Isolated CABG Surger Perioperative 4043F Care: &Discontinuation G8702 4043F-1P &N/A G8702 of Prophylactic N/A Parenteral G8703 Antibiotics 4043F-8P (Cardiac & G8702 Procedures) No Report Medication 1111F Reconciliation N/A N/A N/A No Report 1111F-8P Advance Care 1123F Plan N/A N/A N/A No Report 1123F-8P 1124F Urinary Incontinence: 1090F Assessment 1090F-1P N/A of PresenceN/A or Absence No of Report Urinary 1090F-8P Incontinence in Women Aged 65 Urinary Incontinence: 1091F Characterization N/A N/A of Urinary N/AIncontinence No Report in Women 1091F-8P Aged 65 Years and Older Urinary Incontinence: 0509F Plan N/A of Care N/A for Urinary N/A Incontinence No in Report Women 0509F-8P Aged 65 Years and Older Chronic Obstructive 3023F Pulmonary 3023F-1P Disease 3023F-2P (COPD): 3023F-3P Spirometry NoEvaluation Report 3023F-8P Chronic Obstructive 4025F & Pulmonary G8924 4025F-1P Disease &4025F-2P G8924 (COPD): &4025F-3P G8924 Bronchodilator &G8925 G8924 Therapy 4025F-8P & G8924 G8926 No Report Asthma: Pharmacologic 4140F & 1038F N/A Therapy for 4140F-2P Persistent &N/A 1038F Asthma Ambulatory 1039F 4140F-8P Care Setting & 1038F 4144F & 1038F No Report Emergency 3120F Medicine: 12-Lead 3120F-1P Electrocardiogram 3120F-2P N/A(ECG) Performed No Report for 3120F-8P Non-Traumatic Chest Pain Emergency G8704 Medicine: 12-Lead N/A Electrocardiogram N/A N/A(ECG) Performed G8705 for G8707 Syncope G8706 No Report Emergency 2010F Medicine: Community-Acquired N/A N/A Pneumonia N/A (CAP): No Report Vital Signs 2010F-8P Emergency 4045F Medicine: Community-Acquired 4045F-1P 4045F-2P Pneumonia 4045F-3P (CAP): No Report Empiric 4045F-8P Antibiotic Asthma: Assessment 2015F & 2016F ofN/A Asthma Control N/A Ambulatory N/A Care No Setting Report 2015F-8P 2016F-8P Appropriate G8708 TreatmentN/A for Children N/A with Upper N/A Respiratory G8709 InfectionG8710 (URI) No Report Appropriate 3210F Testing & for G8711 3210F-1P Children with &N/A G8711 Pharyngitis N/A G8712 3210F-8P & G8711 No Report Hematology: 3155F Myelodysplastic 3155F-1P Syndrome 3155F-2P (MDS) 3155F-3P and AcuteNo Leukemias: Report 3155F-8P Baseline Cytogenetic Testing Pe Hematology: 3160F Myelodysplastic & 4090F N/A Syndrome N/A (MDS): 3160F-3P Documentation &4095F 4090F of Iron 3160F-8P Stores in & Patients 4090F Receiving Er No Report Hematology: 4100F Multiple Myeloma: 4100F-1P Treatment 4100F-2P with N/A Bisphosphonates No Report 4100F-8P Hematology: 3170F Chronic Lymphocytic 3170F-1P 3170F-2P Leukemia (CLL): 3170F-3P Baseline NoFlow Report Cytometry 3170F-8P Breast Cancer: 4179F Hormonal & 3374F 4179F-1P Therapy & 3315F &for 4179F-2P 3374F Stage & IC 3315F &4179F-3P -3374F IIIC Estrogen & 3315F &3316F 3374F Receptor/Progesterone & 3315F 4179F-8P & 3374F Receptor & 3315F (ER/PR) 4179F & 3376F 4179F-1P & 3315F &4179F-2P 3376F & 3315F &4179F-3P 3376F & 3315F &3370F 3376F & 3315F 4179F-8P & 3376F & 3315F 4179F & 3378F 4179F-1P & 3315F &4179F-2P 3378F & 3315F &4179F-3P 3378F & 3315F &3372F 3378F & 3315F 4179F-8P & 3378F & 3315F 3380F

72

0385

76 *81 *82 *83 84 85 86 87 89 90 91 93 99 100

0464 0323 0321 0393 0395 0396 0397 0398 0401 0394 0653 0654 0391 0392

102

0389

104 106 107 108 109 110

0390 0103 0104 0054 0050 0041

111 112

0043 0031

3316F-8P 3370F-8P No Report Colon Cancer: G8927 Chemotherapy & 3388F N/A for AJCC N/A Stage III N/A Colon Cancer G8928 Patients & 3388F G8929 & 3388F 3382F 3384F 3386F 3390F 3382F-8P No Report Prevention 6030F of Catheter-Related 6030F-1P Bloodstream N/A Infections N/A (CRBSI): No Report Central 6030F-8P Venous Catheter (CVC) Inserti Adult Kidney G8713 Disease: Hemodialysis N/A N/A Adequacy:N/A Solute No Report G8717 Adult Kidney G8718 Disease: Peritoneal N/A Dialysis N/A Adequacy: N/A Solute No Report G8720 Hepatitis C:3265F Testing for 3265F-1P Chronic Hepatitis 3265F-2P C Confirmation N/A No of Report Hepatitis 3265F-8P C Viremia Hepatitis C:3218F Ribonucleic & 4150F 3218F-1P Acid (RNA) &N/A 4150F Testing Before N/A Initiating 4151F Treatment 3218F-8P & 4150F No Report Hepatitis C:3266F HCV Genotype & G8459 N/A TestingN/A Prior to Treatment N/A G8458 3266F-8P & G8459 No Report Hepatitis C:4153F Antiviral Treatment 4153F-1PPrescribed 4153F-2P 4153F-3P No Report 4153F-8P Hepatitis C:3220F HCV Ribonucleic & G8461 3220F-1P Acid& (RNA) 3220F-2P G8461 Testing &N/A G8461 at Week 12 G8460 of Treatment 3220F-8P & G8461 No Report Hepatitis C:4158F CounselingN/A Regarding Risk N/A of Alcohol N/A Consumption No Report 4158F-8P Hepatitis C:4159F Counseling & G8463 4159F-1P Regarding & Use N/A G8463 of Contraception N/A Prior G8462 to Antiviral 4159F-8P Therapy & G8463 No Report Acute Otitis4130F Externa (AOE): 4130F-1P Topical4130F-2P Therapy N/A No Report 4130F-8P Acute Otitis4132F Externa (AOE): 4131F-1P Systemic N/A Antimicrobial N/A Therapy No Report Avoidance 4131F of Inappropriate Use Breast Cancer 3260F Resection 3260F-1P PathologyN/A Reporting: N/A pT Category 3250F (Primary Tumor) 3260F-8P and pN Category (Regiona No Report Colorectal Cancer G8721 Resection N/A Pathology N/A Reporting: N/A pT Category G8722 (Primary G8724 Tumor) and pN Category (Regi G8723 No Report Prostate Cancer: 3270F Avoidance & 3271F 3269F-1P of Overuse &N/A 3271F of Bone 3269F-3P Scan for& Staging 3272F 3271F Low 3269F Risk Prostate & 3271F Cancer Patients 3273F 3274F No Report Prostate Cancer: 4164F Adjuvant & G8465 4164F-1P Hormonal &4164F-2P G8465 Therapy &for N/A G8465 High Risk G8464 Prostate Cancer 4164F-8P Patients & G8465 No Report Adult Major1040F Depressive & G8930 N/A Disorder (MDD): N/A Comprehensive N/A Diagnostic No Report Evaluation: 1040F-8P & Diagnosis G8931 and Severity Adult MajorG8932 DepressiveN/A Disorder (MDD): N/A Suicide N/A Risk Assessment 3092F G8933 No Report Rheumatoid 4187F Arthritis (RA): 4187F-1P DiseaseN/A Modifying Anti-Rheumatic N/A No Report Drug (DMARD) 4187F-8P Therapy Osteoarthritis 1006F (OA): Function N/A and Pain N/A Assessment N/A No Report 1006F-8P Preventive Care G8482 and Screening: N/A Influenza N/A Immunization N/A G8483 G8484 G0919 No Report Preventive Care 4040F and Screening: 4040F-1P Pneumococcal N/A N/A Vaccination No for Report Patients 4040F-8P 65 Years and Older Preventive Care 3014F and Screening: 3014F-1P Breast N/A Cancer N/A Screening No Report 3014F-8P

113 116 117

0034 0058 0055

*118

0066

119

0062

121 122 123

AQA AQA AQA

126 127 128

0417 0416 0421

130 131

0419 0420

134

0418

*137 *138 140 141 142 *143 *144

0650 0561 0566 0563 0051 0384 0383

Preventive Care 3017F and Screening: 3017F-1P Colorectal N/A Cancer N/AScreening No Report 3017F-8P Antibiotic Treatment 4124F for 4120F-1P Adults with N/A Acute Bronchitis: N/A Avoidance No Report of Inappropriate 4120F Use Diabetes Mellitus: 2022F Dilated N/A Eye Exam N/A N/A No Report 2022F-8P 2024F 2024F-8P 2026F 2026F-8P 3072F Coronary Artery G8935 Disease N/A (CAD): Angiotensin-Converting N/A N/A Enzyme G8936 (ACE) G8937 Inhibitor or Angiotensin Recepto -----------No Report -----------G8473 ------------ G8475 G8474 No Report Diabetes: Medical 3060F Attention N/A for Nephropathy N/A N/A No Report 3060F-8P 3061F 3061F-8P 3062F 3062F-8P 3066F G8506 Adult Kidney G8725 Disease: LaboratoryTesting N/A N/A (LipidN/A Profile) G8726 G8728 No Report Adult Kidney G8476 Disease: Blood N/A Pressure N/A Management N/A No Report G8478 G8477 & 0513F 0513F-8P & G8477 Adult Kidney G0908 Disease: & 4171F Patients N/A On Erythropoiesis-Stimulating N/A N/A G0909 Agent & 4171F (ESA) G0910 - Hemoglobin & 4171F Level > 12.0 g/ (NOTE: A lower performance rate is desirable for 4172F this measure) No Report Diabetes Mellitus: G8404 Diabetic N/A Foot and N/A Ankle Care, N/A Peripheral G8406 Neuropathy G8405 Neurological Evaluation No Report Diabetes Mellitus: G8410 Diabetic N/A Foot and N/A Ankle Care, N/A Ulcer Prevention G8416 Evaluation G8415 of Footwear No Report Preventive Care G8420 and Screening: N/A Body N/A Mass Index N/A (BMI) Screening G8422 andG8421 Follow-Up G8417 G8938 G8419 G8418 No Report Documentation G8427 of Current N/AMedications N/A in the N/A Medical Record G8430 G8428 No Report Pain Assessment G8730 and Follow-Up N/A N/A N/A G8442 G8732 G8731 G8939 G8509 No Report Preventive Care G8431 and Screening: N/A Screening N/A for Clinical N/A Depression G8433 and G8432 Follow-Up Plan G8510 G8940 G8511 No Report Melanoma:7010F Continuity of N/A Care Recall N/A System7010F-3P No Report 7010F-8P Melanoma:5050F Coordination N/A of Care 5050F-2P 5050F-3P No Report 5050F-8P Age-Related 4177F Macular Degeneration N/A N/A (AMD): Counseling N/A onNo Antioxidant Report 4177F-8P Supplement Primary Open-Angle 3284F Glaucoma N/A (POAG): N/A Reduction N/A of Intraocular No Report Pressure 0517F-8P (IOP)& by 3285F 15% OR Documenta 0517F & 3285F 3284F-8P Osteoarthritis 1007F (OA): Assessment N/A for N/A Use of Anti-Inflammatory N/A No Report or Analgesic 1007F-8P Over-the-Counter (OTC) Me Oncology: Medical 1125F and N/A Radiation N/A Pain Intensity N/A Quantified No Report 1125F-8P 1126F Oncology: Medical 0521F and N/A Radiation N/A Plan of Care N/A for Pain No Report 0521F-8P

145 146

0510 0508

147 148 149 150 151 154

0511 0322 0319 0315 0313 AQA

155 156 157 *159 *160 *160

AQA 0382 0455 0404 0405 0405

*161 *161 *162 *162 163 *164 *165 *166 *167 *168 *169

0406 0406 0407 0407 0056 0129 0130 0131 0114 0115 0237

Radiology: Exposure 6045F Time N/A Reported N/A for Procedures N/A Using No Fluoroscopy Report 6045F-8P Radiology: Inappropriate 3343F N/A Use of Probably N/A Benign N/A Assessment No Report Category 3340F in Mammography Screening (NOTE: A lower performance rate is desirable for this measure) 3341F 3342F 3344F 3345F 3350F Nuclear Medicine: 3570F Correlation N/A with N/A Existing Imaging 3570F-3P Studies Nofor Report All Patients 3570F-8P Undergoing Bone Scintigra Back Pain: Initial 1130F Visit N/A N/A N/A 0526F 1130F-8P No Report Back Pain: Physical 2040F Exam N/A N/A N/A 0526F 2040F8P No Report Back Pain: Advice 4245F for Normal N/A Activities N/A N/A 0526F 4245F-8P No Report Back Pain: Advice 4248F Against N/A Bed RestN/A N/A 0526F 4248F-8P No Report Falls: Risk Assessment 3288F & 1100F 3288F-1P &N/A 1100F N/A 1101F 3288F-8P & 1100F 1101F-8P No Report Falls: Plan of 0518F Care 0518F-1P N/A N/A No Report 0518F-8P Oncology: Radiation 0520F Dose N/A Limits toN/A Normal Tissues N/A No Report 0520F-8P Thoracic Surgery: 3323F Recording N/A of Clinical N/A Stage Prior N/A to LungNo Cancer Report or Esophageal 3323F-8P Cancer Resection HIV/AIDS: CD4+ 3500F Cell Count N/A or CD4+ N/A Percentage N/A No Report 3500F-8P Individual Measures 4280F Reporting: 4280F-1P HIV/AIDS: N/A Pneumocystis N/A Jiroveci No Report Pneumonia 4280F-8P (PCP) Prophylaxis Measures Group 4280FReporting: & 3494F 4280F-1P HIV/AIDS: &N/A 3494F Pneumocystis N/A Jiroveci No Report Pneumonia 3494F-8P (PCP) Prophylaxis 3495F 4280F-8P & 3494F 3496F Individual Measures 4276F Reporting: N/A HIV/AIDS: N/A Adolescent N/A andNo Adult Report Patients 4276F-8P with HIV/AIDS Who Are Presc Measures Group 4276FReporting: & 3492F N/A HIV/AIDS: N/A Adolescent N/A and Adult 3493F Patients 4276F-8P with HIV/AIDS & 3492F Who Are Prescribe 4276F & 3490F No Report 4276F-8P & 3490F Individual Measures 3502F Reporting: N/A HIV/AIDS: N/A HIV N/A RNA Control No After Report Six Months 3502F-8P of Potent Antiretroviral Th 3503F & 0575F 0575F-8P & 3503F Measures Group 3502FReporting: & 4270F N/A HIV/AIDS: N/A HIV RNA N/A Control After 4271F Six Months 3502F-8P of Potent & 4270F Antiretroviral Thera 3503F & 0575F & 4270F No Report 0575F-8P & 3503F & 4270F Diabetes Mellitus: 2028F Foot2028F-1P Exam N/A N/A No Report 2028F-8P Coronary Artery G8569 BypassN/A Graft (CABG): N/AProlonged N/A Intubation No Report G8570 (NOTE: A lower performance rate is desirable for this measure) Coronary Artery G8571 BypassN/A Graft (CABG): N/ADeep Sternal N/A Wound No Infection Report Rate G8572 (NOTE: A lower performance rate is desirable for this measure) Coronary Artery G8573 BypassN.A Graft (CABG): N/AStroke N/A No Report G8574 (NOTE: A lower performance rate is desirable for this measure) Coronary Artery G8575 BypassN/A Graft (CABG): N/APostoperative N/A Renal No Failure Report G8576 (NOTE: A lower performance rate is desirable for this measure) Coronary Artery G8577 BypassN/A Graft (CABG): N/ASurgical N/A Re-exploration No Report G8578 (NOTE: A lower performance rate is desirable for this measure) Coronary Artery G8579 BypassN/A Graft (CABG): N/AAntiplatelet N/A Medications G8580 at Discharge G8581 No Report

*170 *171 172 173 176 177

0238 0118 0259 AQA AQA AQA

178 179 180

AQA AQA AQA

181

AQA

182

AQA

183 184 185 *187 188 *191 *192 193 194 195 *197

0399 0400 0659 0437 N/A 0565 0564 0454 0386 0507 0074

*198 201

0079 0073

Coronary Artery G8582 BypassN/A Graft (CABG): N/ABeta-Blockers N/A Administered G8583 at G8584 Discharge No Report Coronary Artery G8585 BypassN/A Graft (CABG): N/AAnti-Lipid N/A Treatment G8586 at Discharge G8587 No Report Hemodialysis G8530 Vascular Access N/A Decision-Making N/A N/A by Surgeon G8531 to Maximize G8532 Placement of Autogenous Arte No Report Preventive Care 3016F and Screening: 3016F-1P Unhealthy N/A Alcohol N/A Use Screening No Report 3016F-8P Rheumatoid 3455F Arthritis & 4195F (RA): 3455F-1P Tuberculosis &N/A 4195F Screening N/A 4196F 3455F-8P & 4195F No Report Rheumatoid 3470F Arthritis (RA): N/APeriodic N/A Assessment N/A of Disease No Activity Report 3470F-8P 3471F 3472F Rheumatoid 1170F Arthritis (RA): N/AFunctional N/AStatus Assessment N/A No Report 1170F-8P Rheumatoid 3475F Arthritis (RA): N/AAssessment N/A and Classification N/A of NoDisease Report Prognosis 3475F-8P 3476F Rheumatoid 4192F Arthritis (RA): 0540F-1P Glucocorticoid &N/A 4194F Management N/A No Report 4194F-8P 4193F 0540F-8P & 4194F 4194F & 0540F Elder Maltreatment G8733 Screen N/A and Follow-Up N/A Plan N/A G8535 G8536 G8734 G8941 G8735 No Report Functional Outcome G8539 Assessment N/A N/A N/A G8540 G8541 G8542 No Report G8543 G8942 Hepatitis C:4148F Hepatitis A4148F-1P Vaccination 4148F-2P in PatientsN/A with HCV No Report 4148F-8P 3215F Hepatitis C:4149F Hepatitis B 4149F-1P Vaccination 4149F-2P in PatientsN/A with HCV No Report 4149F-8P 3216F Endoscopy & 0529F Polyp Surveillance: 0529F-1P Colonoscopy N/A 0529F-3P Interval forNo Patients Report with 0529F-8P a History of Adenomatous Pol Stroke and Stroke G8600 Rehabilitation: N/A Thrombolytic N/A N/A Therapy G8601 G8602 No Report Referral forG8556 Otologic Evaluation N/A forN/A Patients with N/A Congenital G8557 or Traumatic G8558 Deformity of the Ear No Report Cataracts: 20/40 4175F or Better N/AVisual Acuity N/A withinN/A 90 Days Following No Report Cataract 4175F-8P Surgery Cataracts: Complications G8627 N/A within 30N/A Days Following N/A Cataract No Surgery Report Requiring G8628 Additional Surgical Proc (NOTE: A lower performance rate is desirable for this measure) Perioperative 4250F Temperature & 4255F 4250F-1P Management &N/A 4255F N/A 4256F 4250F-8P & 4255F No Report Oncology: Cancer 3300F Stage N/A Documented N/A N/A No Report 3301F-8P 3301F Radiology: Stenosis 3100F Measurement N/A N/A in Carotid Imaging N/A Studies No Report 3100F-8P Coronary Artery G8736 Disease G8737 (CAD): &Lipid 0556F G8737 Control & 4013F-1P & 0556F G8737 & 4013F-2P & 0556F No Report & 4013F-3P G8737 & 4013F-8P G8737 & 4013F & 0556F G8737 & 0556F-8P G8943 Heart Failure: G8738 Left Ventricular N/A Ejection N/A Fraction N/A (LVEF) Assessment No Report G8740 G8739 Ischemic Vascular G8588 Disease & G8590 N/A(IVD): Blood N/A Pressure N/A Management No Report G8588 & G8591

204 *205 *208 *209 *210 *211 *212 *213 *214 *215 *216 *217 *218 *219 *220 221 *222 *223 *224 225 226 *228 231 232

0068 0409 0410 0445 0449 0448 0447 0446 0444 0442 0443 0422 0423 0424 0425 0426 0427 0428 0562 0509 0028 N/A N/A N/A

*233

0457

G8589 & G8590 G8589 & G8591 G8592 Ischemic Vascular G8598 Disease N/A(IVD): Use N/A of Aspirin N/A or Another No Antithrombotic Report G8599 HIV/AIDS: Sexually 3511F Transmitted N/A Disease 3511F-2P Screening N/A for Chlamydia No Report and 3511F-8P Gonorrhea HIV/AIDS: Sexually 3512F Transmitted N/A Disease 3512F-2P Screening N/A for Syphilis No Report 3512F-8P Functional Communication G8603 N/A Measure N/A - Spoken N/A Language Comprehension No Report G8604 G8605 Functional Communication G8606 N/A Measure N/A - Attention N/A No Report G8607 G8608 Functional Communication G8609 N/A Measure N/A - Memory N/A No Report G8610 G8611 Functional Communication G8612 N/A Measure N/A - Motor Speech N/A No Report G8613 G8614 Functional Communication G8615 N/A Measure N/A - ReadingN/A No Report G8616 G8617 Functional Communication G8618 N/A Measure N/A - Spoken N/A Language Expression No Report G8619 G8620 Functional Communication G8621 N/A Measure N/A - Writing N/A No Report G8622 G8623 Functional Communication G8624 N/A Measure N/A - Swallowing N/A No Report G8625 G8626 Functional Deficit: G8647 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8649 for Patients G8650 with Knee Impairments G8648 No Report Functional Deficit: G8651 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8653 for Patients G8654 with Hip Impairments G8652 No Report Functional Deficit: G8655 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8657 for Patients G8658 with Lower Leg, Foot or Ankl G8656 No Report Functional Deficit: G8659 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8661 for Patients G8662 with Lumbar Spine Impairme G8660 No Report Functional Deficit: G8663 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8665 for Patients G8666 with Shoulder Impairments G8664 No Report Functional Deficit: G8667 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8669 for Patients G8670 with Elbow, Wrist or Hand Im G8668 No Report Functional Deficit: G8671 Change N/Ain Risk-Adjusted N/A Functional N/A Status G8673 for Patients G8674 with Neck, Cranium, Mandib G8672 No Report Melanoma:3320F Overutilization 3319F-1P of Imaging N/AStudies 3319F-3P in Melanoma No Report 3319F Radiology: Reminder 7025F System N/A for Mammograms N/A N/A No Report 7025F-8P Preventive Care 4004F and Screening: 4004F-1P Tobacco N/A Use: Screening N/A and NoCessation Report 4004F-8P Intervention 1036F Heart Failure G8682 (HF): Left N/A Ventricular N/A Function (LVF) N/ATesting G8683 G8685 No Report Asthma: Tobacco 1031F Use: Screening N/A - Ambulatory N/A N/A Care Setting No Report 1031F-8P Asthma: Tobacco 4000F Use: & 1032F Intervention N/A N/A - Ambulatory N/A Care Setting 1033F G8751 4001F & 1032F No Report 4000F-8P & 1032F 4001F-8P & 1032F Thoracic Surgery: 3328F Recording N/A of Performance N/A Status N/A Prior to No Lung Report or Esophageal 3328F-8P Cancer Resection

*234 236

0458 0018

241 242* 242* 243* 244*

0075 N/A N/A 0643 N/A

245 246 247 248 249 250 251 252 254 255 256* 257* 258* 259* 260* 261

AQA AQA AQA AQA N/A N/A N/A 0503 0651 0652 N/A N/A N/A N/A N/A N/A

Thoracic Surgery: 3038F Pulmonary 3038F-1P Function N/A Tests Before N/A MajorNo Anatomic Report Lung 3038F-8P Resection (Pneumonectomy Hypertension G8752 (HTN): & G8754 Controlling N/A High N/A Blood Pressure N/A No Report G8752 & G8755 G8753 & G8754 G8753 & G8755 G8756 Ischemic Vascular G8593 Disease & G8595 N/A(IVD): Complete N/A Lipid N/A Panel and No Low Report Density G8594 Lipoprotein (LDL-C) Control G8593 & G8597 Individual Reporting 1011F & 0557F via 1011F Registry: & 0557F-1P Coronary N/A Artery N/A DiseaseNo (CAD): Report Symptom 1011F Management & 0557F-8P 1012F Measures Group 1010FReporting: & 1011F 1010F & Coronary 0557F & 1011F N/AArtery & 0557F-1P Disease N/A (CAD): NoSymptom Report 1010F Management & 1011F & 0557F-8P 1010F & 1012F 1010F-8P Cardiac Rehabilitation 4500F Patient 4500F-1P Referral 4500F-2P from an 4500F-3P Outpatient 4510F Setting 4500F-8P No Report Hypertension: G8790 Blood & G8793 Pressure 4145F-1P Management 4145F-2P 4145F-3P No Report 4145F-8P G8790 & G8794 G8796 G8791 & G8793 G8791 & G8794 G8790 & G8795 & 4145F G8791 & G8795 & 4145F G8792 & G8793 & 4145F G8792 & G8794 & 4145F G8792 & G8795 & 4145F Chronic Wound 4261F Care: Use 4260F-1P of Wound N/A Surface Culture N/A Technique No Report in Patients 4260Fwith Chronic Skin Ulcers (O Chronic Wound 4266F Care: Use 4265F-1P of Wet to N/A Dry Dressings N/A in Patients No Report with Chronic 4265FSkin Ulcers (Overuse Measu Substance Use 4320F Disorders: N/A Counseling N/A Regarding N/A Psychosocial No Report and Pharmacologic 4320F-8P Treatment Options fo Substance Use 1220F Disorders: 1220F-1P Screening N/A for Depression N/A Among No Patients Reportwith 1220F-8P Substance Abuse or Depende Barrett's Esophagus 3125F 3125F-1P N/A N/A G8797 3125F-8P No Report Radical Prostatectomy 3267F Pathology 3267F-1P Reporting N/A N/A G8798 3267F-8P No Report Immunohistochemical 3394F (IHC) N/A Evaluation N/A of Human N/AEpidermal 3395F Growth Factor 3394F-8P Receptor 2 Testing (HER2) No Report Anticoagulation G8799 for Acute N/A Pulmonary N/A EmbolusN/A Patients G8800 G8801 No Report Ultrasound G8806 Determination N/Aof Pregnancy N/A Location N/Afor Pregnant G8807 Patients G8808 with Abdominal Pain No Report Rh Immunoglobulin G8809 (Rhogam) N/A for Rh-Negative N/A N/A Pregnant Women G8810 at Risk G8811 of Fetal Blood Exposure No Report Surveillance G8813 after Endovascular N/A Abdominal N/A Aortic N/AAneurysm G8812 Repair (EVAR) G8814 No Report Statin Therapy G8816 at Discharge N/A after Lower N/A Extremity N/A Bypass G8815 (LEB) G8817 No Report Rate of Open G8818 Repair of N/A Small or Moderate N/A Non-Ruptured N/A Abdominal No Report Aortic G8825Aneurysms (AAA) without Rate of Endovascular G8826 Aneurysm N/A Repair N/A (EVAR)N/A of Small or No Moderate Report Non-Ruptured G8833 Abdominal Aortic A Rate of Carotid G8834 Endarterectomy N/A (CEA) N/Afor Asymptomatic N/A Patients, No Report without G8838 Major Complications (Disch Referral forG8856 Otologic Evaluation N/A forN/A Patients with N/A Acute orG8857 Chronic Dizziness G8858 No Report

262 263

N/A N/A

264* 265* 266 267 268 269* 270* 271* 272* 273*

N/A 0645 N/A N/A N/A N/A N/A N/A N/A N/A

274* 275*

N/A N/A

276* 277* 278*

N/A N/A N/A

279*

N/A

280*

N/A

281* 282* 283* 284* 285* 286*

N/A N/A N/A N/A N/A N/A

Image Confirmation G8872 of N/A Successful Excision N/A of ImageLocalized N/A G8873 Breast G8874 Lesion No Report Preoperative G8875 DiagnosisN/A of Breast Cancer N/A N/A G8876 G8877 G8946 No Report Sentinel Lymph G8878 Node Biopsy N/A for Invasive N/A Breast N/A Cancer G8880 G8882 No Report Biopsy Follow-Up G8883 N/A N/A N/A G8884 G8885 No Report Epilepsy: Seizure 1200FType(s) 1200F-1P and Current 1200F-2P Seizure Frequency(ies) N/A No Report 1200F-8P Epilepsy: Documentation 1205F N/A of Etiology N/A of Epilepsy N/A or Epilepsy No Syndrome Report 1205F-8P Epilepsy: Counseling 4340F for 4340F-1P Women of N/A Childbearing N/A PotentialNo with Report Epilepsy 4340F-8P Inflammatory G0920 Bowel Disease N/A (IBD):G0921 Type, Anatomic N/A Location No and Report Activity G0922 All Documented Inflammatory G8859 Bowel & 4142F Disease G8859(IBD): & 4142F-1P G8859 Preventive & 4142F-2P N/A Care: Corticosteroid 3750F Sparing G8859Therapy & 4142F-8P No Report Inflammatory G8860 Bowel & G8861 Disease N/A (IBD):N/A PreventiveN/A Care: Corticosteroid G8862 Related G8860Iatrogenic & G8863 Injury Bone Lo No Report Inflammatory 4035F Bowel Disease 4035F-1P (IBD):4035F-2P Preventive4035F-3P Care: Influenza No Report Immunization 4035F-8P 4037F 4037F-1P 4037F-2P 4037F-3P 4037F-8P Inflammatory G8864 Bowel Disease N/A (IBD):N/A PreventiveN/A Care: Pneumococcal G8865 Immunization G8867 G8866 No Report Inflammatory 3510F Bowel & G8868 Disease 3510F-1P (IBD): &3510F-2P G8868 Testing for &N/A Latent G8868 Tuberculosis No Report (TB) 3510F-8P Before Initiating & G8868 Anti-TNF (Tum 6150F Inflammatory 3517F Bowel Disease 3517F-1P (IBD):3517F-2P Assessment N/A of Hepatitis G8871 B Virus (HBV) 3517F-8P Status Before Initiating AntiG8869 No Report G8870 Sleep Apnea: G8839 Assessment N/A of Sleep N/A Symptoms N/A G8840 G8841 No Report Sleep Apnea: G8842 Severity Assessment N/A N/A at Initial Diagnosis N/A G8843 G8844 No Report Sleep Apnea: G8845 Positive & G8846 Airway N/A Pressure N/A Therapy N/A Prescribed G8848 G8850 & G8846 G8849 & G8846 No Report Sleep Apnea: G8851 Assessment & G8852 N/A of Adherence N/A to Positive N/A Airway G8853 Pressure Therapy G8855 & G8852 G8854 & G8852 No Report Dementia: Staging 1490F of Dementia N/A N/A N/A No Report 1490F-8P 1491F 1493F Dementia: Cognitive 1494F Assessment 1494F-1P 1494F-2P N/A No Report 1494F-8P Dementia: Functional 1175F Status 1175F-1P Assessment N/A N/A No Report 1175F-8P Dementia: Neuropsychiatric 1181F N/A Symptom N/A Assessment N/A No Report 1181F-8P Dementia: Management G8947 & 4525F N/A of Neuropsychiatric N/A Symptoms N/A G8948 G8947 & 4525F-8P G8947 & 4526F No Report G8947 & 4526F-8P Dementia: Screening 3725F for N/A Depressive N/A Symptoms N/A No Report 3725F-8P Dementia: Counseling 6101F Regarding 6101F-1P Safety N/A Concerns N/A No Report 6101F-8P

287* 288* 289* 290* 291* 292* 293* 294* 295* 296* 297* 298* 299* 300* 301*

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

302*

N/A

303* 304* 317

N/A N/A N/A

320 321 322* 323* 324* 325* 326

0658 0493 0670 0671 0672 N/A 1525

6102F 6102F-1P 6102F-8P Dementia: Counseling 6110F Regarding 6110F-1P Risks N/A of Driving N/A No Report 6110F-8P Dementia: Caregiver 4322F Education 4322F-1P and N/A Support N/A No Report 4322F-8P Parkinsons 1400F Disease: Annual N/A Parkinsons N/A Disease N/A Diagnosis No Review Report 1400F-8P Parkinsons 3700F Disease: Psychiatric N/A Disorders N/A or Disturbances N/A No Assessment Report 3700F-8P Parkinsons 3720F Disease: Cognitive N/A Impairment N/A or Dysfunction N/A No Assessment Report 3720F-8P Parkinsons 4328F Disease: Querying 4328F-1P about N/A Sleep Disturbances N/A No Report 4328F-8P Parkinsons 4400F Disease: Rehabilitative 4400F-1P N/A Therapy Options N/A No Report 4400F-8P Parkinsons 4325F Disease: Parkinsons 4325F-1P Disease N/A Medical N/Aand Surgical No Report Treatment 4325F-8P Options Reviewed Hypertension: G8895 Appropriate N/A Use of Aspirin N/A or Other N/A Anththrombotic G8896 Therapy G8897 No Report Hypertension: G8767 Complete N/A Lipid Profile N/A N/A G8768 G8769 No Report Hypertension: G8770 Urine Protein N/A Test N/A N/A G8772 G8773 G8771 No Report Hypertension: G8774 Annual Serum N/A Creatinine N/A Test N/A G8775 G8776 No Report Hypertension: G8777 DiabetesN/A Mellitus Screening N/A Test N/A G8778 G8779 No Report Hypertension: G8886 Blood Pressure N/A Control N/A N/A G8887 G8888 No Report G8889 Hypertension: G8890 Low Density N/A Lipoprotein N/A (LDL-C) N/A Control G8891 G8893 G8892 G8894 No Report Hypertension: G8780 Dietary and N/APhysicalN/A Activity Modifications N/A G8781 Appropriately G8782 Prescribed G8949 No Report Cataracts: Improvement G0913 N/A in Patients N/A Visual Function N/A within G0914 90 Days Following G0915 Cataract Surgery No Report Cataracts: Patient G0916 Satisfaction N/A within N/A 90 Days Following N/A Cataract G0917 Surgery G0918 No Report Preventive Care G8783 and Screening: N/A Screening N/A for High N/A Blood Pressure G8784 and G8785 Follow-Up Documented G8950 G8951 G8952 No Report Endoscopy/Polyp 0528F Surveillance: 0528F-1P Appropriate N/A Follow-Up N/A Interval No Report for Normal 0528F-8P Colonoscopy in Average Ris Participation G8954 by a Hospital, N/A Physician N/A or Other N/A Clinician in No a Systematic Report N/A Clinical Database Registry that Cardiac Stress G8961 Imaging Not N/A Meeting N/A Appropriate N/A Use Criteria: No Report Preoperative G8962Evaluation in Low Risk Surg (NOTE: A lower performance rate is desirable for this measure) Cardiac Stress G8963 Imaging Not N/A Meeting N/A Appropriate N/A Use Criteria: No Report Routine G8964 Testing After Percutaneous Coro (NOTE: A lower performance rate is desirable for this measure) Cardiac Stress G8965 Imaging Not N/A Meeting N/A Appropriate N/A Use Criteria: No Report TestingG8966 in Asyptomatic, Low-Risk Patient (NOTE: A lower performance rate is desirable for this measure) Adult MajorG8959 DepressiveN/A Disorder (MDD): N/A Coordination N/A of Care No Report of Patients G8960 with Comorbid Conditions Atrial Fibrillation G8967 and & G8972 Atrial N/A Flutter:N/A Chronic Anticoagulation N/A G8968 Therapy & G8972 G8971 & G8972 G8969 & G8972 G8970 No Report

327 328

N/A 1667

Pediatric Kidney G8955 Disease: & G8956 N/A Adequacy N/A of VolumeN/A Management G8957 G8958 & G8956 No Report Pediatric Kidney G8973 Disease: N/A ESRD Patients N/A Receiving N/A Dialysis: G8974 Hemoglobin G8976 Level < 10 g/dL (NOTE: A lower performance rate is desirable for G8975 this measure) No Report

Performance

indicates better control.)

G8919 & G8922 G8920 & G8921 G8920 & G8922

4010F-8P & 3021F

5010F-8P & G8397

4049F-8P & 4046F

6010F-8P & 6015F

4043F-8P & G8702

4025F-8P & G8924

4140F-8P & 1038F

3210F-8P & G8711

3160F-8P & 4090F

4179F-8P & 3374F & 3315F 4179F-8P & 3376F & 3315F 4179F-8P & 3378F & 3315F

G8929 & 3388F

3218F-8P & 4150F 3266F-8P & G8459

3220F-8P & G8461

4159F-8P & G8463

3269F & 3271F

4164F-8P & G8465 1040F-8P & G8931

0513F-8P & G8477 G0910 & 4171F

0517F-8P & 3285F

3288F-8P & 1100F

4280F-8P & 3494F

4276F-8P & 3492F 4276F-8P & 3490F 0575F-8P & 3503F 3502F-8P & 4270F 0575F-8P & 3503F & 4270F

3455F-8P & 4195F

0540F-8P & 4194F

4250F-8P & 4255F

G8737 & 4013F-8P G8737 & 0556F-8P

G8588 & G8591

G8589 & G8590 G8589 & G8591

4000F-8P & 1032F 4001F-8P & 1032F

G8752 & G8755 G8753 & G8754 G8753 & G8755

G8593 & G8597 1011F & 0557F-8P 1010F & 1011F & 0557F-8P

G8859 & 4142F-8P G8860 & G8863

3510F-8P & G8868

G8850 & G8846

G8855 & G8852

G8947 & 4525F-8P G8947 & 4526F-8P

G8971 & G8972

G8958 & G8956